Abstract
The molecular motor myosin undergoes a series of major structural transitions during its force-producing motor cycle. The underlying mechanism and its coupling to ATP hydrolysis and actin binding are only partially understood, mostly due to sparse structural data on actin-bound states of myosin. Here, we report 26 high-resolution cryo-EM structures of the actomyosin-V complex in the strong-ADP, rigor, and a previously unseen post-rigor transition state that binds the ATP analog AppNHp. The structures reveal a high flexibility of myosin in each state and provide valuable insights into the structural transitions of myosin-V upon ADP release and binding of AppNHp, as well as the actomyosin interface. In addition, they show how myosin is able to specifically alter the structure of F-actin.
Research organism: Chicken, Human, Rabbit
Introduction
The molecular motor myosin is well known for its central role in muscle contraction (Hanson and Huxley, 1953; Szent-Györgyi, 2004). By using the actin cytoskeleton as tracks, myosin also powers cellular cargo transport processes and can serve as a molecular anchor and force sensor (Hartman et al., 2011; Woolner and Bement, 2009). Due to its versatility, myosin is key to numerous essential cellular processes including cytokinesis, transcription, signal transduction, cell migration and adhesion, and endo- and exocytosis (Coluccio, 2020; Krendel and Mooseker, 2005). While this variety in functions is well reflected by the diversity of the myosin superfamily (Sellers, 2000), the ATP-dependent force generation mechanism as well as the architecture of the motor domain is shared by all myosins (Cope et al., 1996).
The myosin motor domain consists of four subdomains: the actin-binding upper and lower 50 kDa (U50 and L50) domains, which are separated by the central actin-binding cleft, the N-terminal domain, and the converter domain, containing the long α-helical extension known as the lever arm (Rayment et al., 1993b). The active site of myosin is located at the interface of the U50 domain and the N-terminal domain and is allosterically coupled to both the actin-binding interface and the lever arm (Sweeney and Houdusse, 2010). This coupling ultimately enables the amplification of small rearrangements at the active site to large, force-producing conformational changes of the lever arm (Holmes, 1997; Rayment et al., 1993a).
The ATP-driven mechanism of myosin force generation relies on several major structural transitions and is described in the myosin motor cycle (Huxley, 1958; Lymn and Taylor, 1971). Initially, hydrolysis of ATP places myosin in a conformation known as the pre-powerstroke (PPS) state. The mechano-chemical energy stored in this conformation is released by binding to filamentous actin (F-actin), which serves as an activator and initiates a cascade of allosteric structural changes (Rosenfeld and Sweeney, 2004; Walker et al., 2000). These changes eventually result in phosphate release—potentially via a phosphate release (PiR) state (Llinas et al., 2015)—and the major, force-producing lever arm swing known as the powerstroke. Subsequent release of ADP from myosin in a state that binds both F-actin and ADP strongly (strong-ADP state) gives rise to a second, smaller lever arm swing, leaving myosin strongly bound to F-actin in the rigor state (Whittaker et al., 1995; Mentes et al., 2018). Binding of ATP to the now unoccupied active site causes a transition to the post-rigor state and eventual detachment from F-actin (Kühner and Fischer, 2011). Finally, ATP hydrolysis triggers the repriming of the lever arm through the so-called recovery stroke, thus completing the myosin motor cycle.
Decades of biochemical studies have brought great insights into the diversity and kinetics of the myosin superfamily (Coluccio, 2020; Geeves et al., 2005). However, detailed structural information is ultimately required to understand the mechanism of force generation. Over the years, X-ray crystallography has revealed the structures of various myosins in the post-rigor state (Rayment et al., 1993b), the PPS state (Smith and Rayment, 1996), the rigor-like state (Coureux et al., 2003), a putative PiR state (Llinas et al., 2015), as well as the intermediate recovery stroke state (Blanc et al., 2018; for a recent review of all available crystal structures, see Sweeney et al., 2020). Due to the reluctance of F-actin to crystallize, actin-bound states of myosin are not accessible by X-ray crystallography. Instead, cryo electron microscopy (cryo-EM) has proven to be an optimal tool to study filamentous proteins (Pospich and Raunser, 2018) such as the actomyosin complex (Behrmann et al., 2012; von der Ecken et al., 2016). To date, the structure of the actomyosin rigor complex has been determined for a variety of myosins (Banerjee et al., 2017; Behrmann et al., 2012; Doran et al., 2020; Fujii and Namba, 2017; Gong et al., 2021; Gurel et al., 2017; Mentes et al., 2018; Risi et al., 2021; Robert-Paganin et al., 2021; Vahokoski et al., 2020; von der Ecken et al., 2016). States other than the nucleotide-free rigor state have proven more difficult to study, mainly due to lower binding affinities and short lifetimes. In fact, the only other state solved to date is the strong-ADP state; and only two (myosin-IB, myosin-XV) (Gong et al., 2021; Mentes et al., 2018) of four independent studies (myosin-Va, myosin-VI) (Gurel et al., 2017; Wulf et al., 2016) have achieved high resolution (<4 Å). However, the actin-bound states of myosin, in particular weakly bound transition states for which no structure is yet available, are precisely those that are urgently needed to understand important properties of the myosin motor cycle, such as binding to and detachment from F-actin (recently reviewed in Schröder, 2020). In addition, high-resolution structures of other myosins in the rigor and especially strong-ADP state are required to identify conserved and specific features within the myosin superfamily. Finally, structures of all key states of the motor cycle need to be determined for a single myosin to allow the assembly of a reliable structural model since the structures of different myosins vary considerably within the same state (Merino et al., 2020).
Some myosins, including myosin-IB and the high-duty ratio myosins V and VI, have comparatively high binding affinities for F-actin and long lifetimes of actin-bound states (De La Cruz and Ostap, 2004; De La Cruz et al., 2001; De La Cruz et al., 1999; Laakso et al., 2008). Therefore, they are best suited to structurally study actin-bound states other than the rigor. Today, class V and VI myosins are probably the best-characterized unconventional myosins, both structurally and biochemically (Coluccio, 2020). Cryo-EM studies of actomyosin-V have further reported structures of the strong-ADP and rigor state (Wulf et al., 2016), as well as a potential PPS transition state (Volkmann et al., 2005). However, due to the limited resolution of these structures, atomic details could not be modeled and the structural transition of actin-bound myosin-V during its motor cycle has consequently remained elusive. Interestingly, myosin-V was also shown to be sensitive to the nucleotide state of phalloidin (PHD)-stabilized F-actin, preferring young ATP/ADP-Pi-bound F-actin over aged (post-Pi release) ADP-bound F-actin (Zimmermann et al., 2015). The structural basis and implications of this preference have not yet been uncovered.
Here, we present high-resolution cryo-EM structures of the actomyosin-V complex in three nucleotide states. Specifically, we have solved the structure of myosin-V in the strong-ADP state (ADP), the rigor state (nucleotide free), and a previously unseen post-rigor transition (PRT) state, which has the non-hydrolyzable ATP analog AppNHp bound to its active site. To investigate the structural effect the nucleotide state of F-actin has on myosin-V, we have also determined the structure of the rigor complex starting from young ADP-Pi-bound F-actin, rather than from aged ADP-bound F-actin. In addition to these structures and their implications, we report a pronounced conformational heterogeneity of myosin-V in all our data sets and characterize it in detail based on 18 high-resolution subset structures.
Results and discussion
High-resolution cryo-EM structures of the actomyosin-V complex
To provide insights into the structural transitions of myosin along its motor cycle, we determined the structure of the actomyosin-V complex in three different nucleotide states using single-particle cryo-EM. Specifically, we have decorated aged ADP-bound F-actin (rabbit skeletal α-actin) stabilized by PHD (Lynen and Wieland, 1938) with myosin-Va –S1 fragment bound to one essential light chain, hereafter referred to as myosin-V. The complex, referred to as aged actomyosin-V, was either prepared in the absence of a nucleotide or after brief incubation of myosin with Mg2+-ADP or Mg2+-AppNHp (see Materials and methods for details). AppNHp, also known as AMPPNP, is an ATP analog that has been shown to be non-hydrolyzable by myosin-V (Yengo et al., 2002). It is coordinated similarly to ATP in crystal structures of myosin-II (Bauer et al., 2000; Gulick et al., 1997) and has also been reported to lead to a mixture of a pre- and post-powerstroke conformations in myosin-V (Yengo et al., 2002; Volkmann et al., 2005). These results suggest that AppNHp can potentially mimic both ATP and ADP-Pi and is thus well suited to capture short-lived actin-bound transition states, such as the weakly bound PPS and post-rigor states (Sweeney and Houdusse, 2010).
We collected cryo-EM data sets of the different samples (Table 1) and processed them using the helical processing pipeline implemented in the SPHIRE package (Moriya et al., 2017; Pospich et al., 2021; Stabrin et al., 2020), which applies helical restraints but no symmetry. For each data set, two all-particle density maps were reconstructed (Figure 1—figure supplement 1, see Materials and methods for details). In this way, we achieved nominal resolutions of 3.0 Å/3.1 Å (ADP), 3.2 Å/3.3 Å (rigor), and 2.9 Å/2.9 Å (AppNHp), respectively (Figure 1—figure supplement 1 and Figure 1—figure supplement 2, Table 2, Table 3, Table 4), allowing us to reliably model each state and analyze its molecular interactions.
Table 1. Data collection statistics of F-actin and actomyosin data sets.
Aged F-actin-PHD | Young F-actin-JASP | ||||||
---|---|---|---|---|---|---|---|
Microscopy | ADP | Rigor | AppNHp 4°C | AppNHp 25°C | AppNHp* | Actin only | Rigor |
Microscope | Titan Krios – Cs 2.7 mm | Titan Krios – Cs-corrected | |||||
Voltage (kV) | 300 | ||||||
Camera | K2 – super resolution | ||||||
Energy filter slit width (eV) | 20 | ||||||
Pixel size (Å) | 1.06 | 1.10 | |||||
Frames per movie | 40 | ||||||
Exposure time (s) | 15 | ||||||
Total electron dose (e/Å2) | 79 | 82 | 81 | 81 | 81 | 80 | 80 |
Final electron dose (e/Å2) | Dose weighted | Polished particles | |||||
Defocus range (µm) | 0.3–3.2 | 0.5–3.0 | 0.3–3.0 | 0.3–3.0 | 0.3–3.0 | 0.3–2.9 | 0.3–3.0 |
Number of images† | 4571 (5908) | 2304 (3623) | 5858 (7121) | 6617 (7023) | 12,475 | 936 (1064) | 2970 (3336) |
Combined from two data sets (4°C and 25°C).
In parenthesis is the initial number of images.
Table 2. Statistics of aged actomyosin in the strong-ADP state.
Strong-ADP state: aged F-actin-PHD + myosin-Va-LC + Mg2+-ADP | ||||||||
---|---|---|---|---|---|---|---|---|
Central 3er/2er | Central 1er(subtracted) | Class 2 | Class 3 | Class 4 | Class 5 | Class 6 | Class 7 | |
3D refinement statistics | ||||||||
Number of helical segments | 871,844 | 871,844 | 140,383 | 107,848 | 113,766 | 107,961 | 118,875 | 104,552 |
Resolution (Å) | 3.0 | 3.1 | 3.5 | 3.5 | 3.7 | 3.6 | 3.6 | 3.7 |
Map sharpeningfactor (Å2) | –60 | –60 | –78 | –78 | –94 | –86 | –83 | –88 |
Atomic model statistics | ||||||||
Non-hydrogen atoms | 23,334 | 10,171 | 10,149 | 10,149 | 10,086 | 10,066 | 10,113 | 10,139 |
Cross-correlation masked | 0.85 | 0.83 | 0.83 | 0.83 | 0.80 | 0.82 | 0.83 | 0.80 |
MolProbity score | 1.35 | 1.23 | 1.28 | 1.36 | 1.38 | 1.36 | 1.35 | 1.39 |
Clashscore | 6.28 | 4.55 | 5.31 | 6.45 | 6.94 | 6.50 | 6.37 | 7.15 |
EMRinger score* | 3.42/2.83 | 3.56/3.36 | 3.44/3.49 | 2.83/2.92 | 2.67/2.23 | 2.99/2.92 | 2.92/2.52 | 2.68/2.38 |
Bond RMSD (Å) | 0.012 | 0.005 | 0.004 | 0.005 | 0.005 | 0.004 | 0.006 | 0.008 |
Angle RMSD (°) | 1.07 | 0.83 | 0.85 | 0.89 | 0.92 | 0.88 | 0.93 | 1.06 |
Rotamer outliers (%) | 0.04 | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 |
Ramachandranfavored (%) | 99.65 | 99.68 | 99.76 | 99.68 | 99.84 | 99.84 | 99.84 | 99.84 |
Ramachandranoutliers (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CaBLAM outliers (%) | 0.7 | 0.9 | 1.1 | 1.3 | 1.2 | 1.0 | 0.8 | 1.4 |
Values correspond to score against the post-refined map used for real-space refinement/a map filtered to local resolution.
Table 3. Statistics of aged actomyosin in the rigor state.
Rigor state: aged F-actin-PHD + myosin-Va-LC | |||||
---|---|---|---|---|---|
Central 3er/2er | Central 1er(subtracted) | Class 1 | Class 2 | Class 4 | |
3D refinement statistics | |||||
Number of helical segments | 299,784 | 299,784 | 94,077 | 102,818 | 81,757 |
Resolution (Å) | 3.2 | 3.3 | 3.5 | 3.5 | 3.6 |
Map sharpening factor (Å2) | –81 | –80 | –89 | –89 | –87 |
Atomic model statistics | |||||
Non-hydrogen atoms | 23,288 | 10,148 | 10,139 | 10,139 | 10,139 |
Cross-correlation masked | 0.83 | 0.86 | 0.83 | 0.82 | 0.81 |
MolProbity score | 1.28 | 1.18 | 1.24 | 1.25 | 1.31 |
Clashscore | 5.25 | 3.97 | 4.66 | 4.81 | 5.75 |
EMRinger score* | 3.14/3.39 | 3.41/3.10 | 2.97/3.00 | 3.53/3.00 | 3.01/3.06 |
Bond RMSD (Å) | 0.005 | 0.014 | 0.005 | 0.005 | 0.005 |
Angle RMSD (°) | 0.84 | 1.14 | 0.80 | 0.84 | 0.82 |
Rotamer outliers (%) | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 |
Ramachandran favored (%) | 99.86 | 99.84 | 99.60 | 99.76 | 99.76 |
Ramachandran outliers (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CaBLAM outliers (%) | 0.8 | 0.9 | 0.9 | 0.9 | 0.8 |
Values correspond to score against the post-refined map used for real-space refinement/a map filtered to local resolution.
Table 4. Statistics of aged actomyosin in the post-rigor transition (PRT) state.
|
Post-rigor transition state: aged F-actin-PHD + myosin-Va-LC + Mg2+-AppNHp | |||||||
---|---|---|---|---|---|---|---|---|
Central 3er/2er | Central 1er(subtracted) | Class 1 | Class 3 | Class 4 | Class 5 | Class 6 | Class 8 | |
3D refinement statistics | ||||||||
Number of helical segments | 2,446,218 | 2,446,218 | 330,197 | 365,722 | 350,069 | 321,218 | 277,487 | 343,500 |
Resolution (Å) | 2.9 | 2.9 | 3.4 | 3.3 | 3.4 | 3.3 | 3.4 | 3.3 |
Map sharpening factor (Å2) | –80 | –100 | –113 | –106 | –114 | –106 | –111 | –104 |
Atomic model statistics | ||||||||
Non-hydrogen atoms | 23,370 | 10,189 | 10,125 | 10,189 | 10,154 | 10,189 | 10,085 | 10,189 |
Cross-correlation masked | 0.85 | 0.84 | 0.84 | 0.86 | 0.85 | 0.85 | 0.83 | 0.84 |
MolProbity score | 1.25 | 1.15 | 1.17 | 1.24 | 1.20 | 1.26 | 1.37 | 1.18 |
Clashscore | 4.76 | 3.56 | 3.78 | 4.64 | 4.12 | 4.99 | 6.74 | 3.95 |
EMRinger score* | 3.29/3.45 | 3.82/3.40 | 3.35/3.07 | 3.58/3.45 | 3.18/3.35 | 2.94/2.97 | 3.01/3.01 | 3.09/2.88 |
Bond RMSD (Å) | 0.004 | 0.012 | 0.009 | 0.014 | 0.009 | 0.014 | 0.009 | 0.005 |
Angle RMSD (°) | 0.78 | 1.01 | 0.96 | 1.15 | 0.97 | 1.14 | 1.08 | 0.81 |
Rotamer outliers (%) | 0.08 | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 |
Ramachandran favored (%) | 99.86 | 99.84 | 99.84 | 99.84 | 99.84 | 99.84 | 99.84 | 99.84 |
Ramachandran outliers (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CaBLAM outliers (%) | 1.1 | 1.2 | 1.1 | 1.1 | 1.2 | 1.2 | 1.4 | 0.7 |
Values correspond to score against the post-refined map used for real-space refinement/a map filtered to local resolution.
Varying conformations in the strong-ADP state of different myosins
The structure of F-actin decorated with myosin-V in complex with Mg2+-ADP represents the strong-ADP state, which has high affinity for both F-actin and ADP and directly precedes the nucleotide-free rigor state within the myosin motor cycle. The overall structure encompasses all hallmarks of the strong-ADP state including a closed actin-binding cleft, which allows strong binding to F-actin, and a post-powerstroke lever arm orientation (Figure 1, Figure 1—video 1), in line with an earlier medium-resolution structure of the same complex (Wulf et al., 2016).
The density corresponding to Mg2+-ADP is pronounced, indicating high to complete saturation of the active site (Figure 1, Figure 1—figure supplement 3). The β-phosphate of ADP is tightly coordinated by the P-loop (aa 164–168) via a conserved Walker-A nucleotide binding motif (Walker et al., 1982), which is also found in other ATPases as well as G-proteins (Kull and Endow, 2013; Vale, 1996).
The HF helix (aa 169–183) and switch I (aa 208–220) mediate additional contacts by either directly binding to the β-phosphate or coordinating the Mg2+ ion (Figure 1B and C). The third key loop of the active site, switch II (aa 439–448), does not directly contribute to the binding of Mg2+-ADP, which is in agreement with its proposed role in ATP hydrolysis and the subsequent release of the inorganic phosphate (Sweeney et al., 2020). Yet, switch II contributes to the stability of the active site by forming a hydrogen bond with the HF helix (D437-T170, predicted by PDBsum; Laskowski et al., 2018). In addition to the coordination of the β-phosphate, ADP binding is mediated by primarily hydrophobic interactions of the adenosine moiety with the purine-binding loop (Bloemink et al., 2020) (aa 111–116)—for brevity, hereafter referred to as A-loop (adenosine-binding loop) (Figure 1B and C, Figure 1—video 1, Figure 1—figure supplement 3). A tyrosine (Y119) trailing the A-loop forms another putative hydrogen bond with the adenosine, completing the coordination of ADP.
The coordination of Mg2+-ADP in our structure closely resembles the ones reported for the strong-ADP state of myosin-IB (Mentes et al., 2018), myosin-VI (Gurel et al., 2017), and myosin-XV (Gong et al., 2021; Figure 1—figure supplement 4). Only the position of switch I differs appreciably between myosins, ultimately resulting in varying positions of the coordinated Mg2+ ion. These differences highlight that while the general architecture of the active site is common to all myosins, small local reorganizations occur and possibly account for the different kinetics within the myosin superfamily. In contrast to the similarities of the active site, the overall structures of the strong-ADP states of myosin-V, -IB, and -XV differ considerably, resulting in lever arm orientations deviating by 71° and 22°, respectively (Figure 1—figure supplement 5).
Structural transition of myosin-V upon ADP release
The structure of the actomyosin-V complex in the absence of any nucleotide in myosin represents the rigor state (Figure 2, Figure 2—video 1). In addition to an unoccupied and open active site (Figure 2—video 1, Figure 1—figure supplement 3), the actin-binding cleft is closed, facilitating strong binding to F-actin, and the lever arm adopts a post-powerstroke orientation (Figure 2, Figure 2—video 1). These features are common to all rigor structures solved to date (Banerjee et al., 2017; Behrmann et al., 2012; Doran et al., 2020; Fujii and Namba, 2017; Gong et al., 2021; Gurel et al., 2017; Mentes et al., 2018; Risi et al., 2021; Robert-Paganin et al., 2021; Vahokoski et al., 2020; von der Ecken et al., 2016). Yet, the structures of different myosins vary, particularly in the orientation of the lever arm (Figure 1—figure supplement 5A).
Figure 2. Structure of the aged actomyosin-V complex in the rigor state.
(A) Atomic model and LAFTER density map of the central myosin-V-LC subunit (red, LC: white) bound to aged F-actin-PHD (shades of sea green, three subunits shown, A-1 to A+1). Nucleotides and PHD are highlighted in orange and yellow, respectively. (B) Illustration of the model-map agreement within a central section of myosin. Most side chains are resolved by the post-refined density map (transparent gray). See Figure 2—video 1 for a three-dimensional visualization. (C–F) Comparison of the rigor state of myosin-V with crystal structures of the same myosin in the rigor-like state (PDB: 1OE9; Coureux et al., 2003; and PDB: 1W7I, also called weak-ADP state; Coureux et al., 2004; shades of gray). (C) Superposition of atomic models illustrating that deviations are limited to the actin interface, particularly (D) the CM loop, loop 4, and loop 2 and (E) the lever arm. Interestingly, the lever arm orientation seen in the rigor-like states does not superimpose with any conformation seen for the rigor complex (average: red; and 3D classes: transparent red), but localizes outside of its conformational space. (F) The active site is open in both the rigor and rigor-like states, and the SO4 and ADP bound to the rigor-like crystal structures only give rise to small, isolated changes of the P-loop (highlighted by a black arrowhead). Differences in the rigor-like structure can be readily attributed to the absence of F-actin and crystal packing, respectively.
Figure 2—video 1. Structure of the aged actomyosin-V complex in the rigor state.
While the actomyosin interface of the rigor state of myosin-V is basically indistinguishable from the one in the strong-ADP state, the lever arm orientations of the two states differ by ~9° (Figure 3A, Figure 3—video 1A), in agreement with a previously reported rotation of 9.5° (Wulf et al., 2016). The overall architecture of our rigor state structure not only is in good agreement with the medium-resolution cryo-EM structure published earlier (Wulf et al., 2016), but also strongly resembles the rigor-like crystal structures solved for this myosin isoform (Figure 2C–F; Coureux et al., 2003; Coureux et al., 2004).
Figure 3. Structural transition of myosin-V upon Mg2+-ADP release.
(A) Superposition of the strong-ADP (orange) and rigor (red) atomic models. Changes at the active site (black box) are not transmitted to the actomyosin interface, but to the N-terminal and converter domain, resulting in a lever swing of 9°. (B) Close-up view of the active site showing the structural rearrangements upon Mg2+-ADP release (indicated by black arrows). The rigor structure is shown as transparent; see Figure 1 for color code. (C) Illustration of domain movements associated with Mg2+-ADP release predicted by DynDom (Hayward and Lee, 2002). Identified domains correlate well with myosins structural domains (see Figure 1—figure supplement 6) with domain 1 (yellow, 452 residues), domain 2 (181 residues, blue), and domain 3 (93 residues, red) representing the L50 and U50 domains, the N-terminal domain, and the converter domain, respectively. Bending residues primarily localize to the P-loop, the A-loop, and the central transducer β-sheet (1–2, green), as well as to a small part of the N-terminal and converter domain (2–3, purple). (D) Scheme illustrating the structural changes associated with Mg2+-ADP release. (E) Same views as in (D), but colored by DynDom domains, also see (C). The HF helix and the lever arm are highlighted by a black and a yellow arrowhead, respectively. Models were aligned on F-actin. See Figure 3—video 1 for a three-dimensional visualization.
Figure 3—video 1. Structural transition of myosin-V upon ADP release.
As the strong-ADP and rigor state represent sequential states within the myosin motor cycle, a comparison of the respective high-resolution structures allows the detailed description of the structural transition of myosin-V upon Mg2+-ADP release (Figure 3, Figure 3—video 1). In addition to the ~9° lever arm rotation described above (Figure 3A), the two sequential states differ primarily in their conformation of the central transducer β-sheet and the N-terminal domain, which twist and rotate, respectively (Figure 3C–E, Figure 3—video 1; see Figure 1—figure supplement 6 for an overview of the myosin domain architecture). Notably, the structural changes are not transmitted to the U50 and L50 domains and thus do not alter the actin-binding interface (Figure 3A and C, Figure 3—video 1A and B).
The transducer rearrangements are directly linked to a reorganization of the active site that accounts for the reduced Mg2+-ADP affinity of the rigor state. By promoting a piston movement of the HF helix, twisting of the transducer increases the distance between the P-loop and switch I, thereby opening the active site (Figure 3B and D, Figure 3—video 1A–C). The resulting conformation is incompatible with the Mg2+-coordinating hydrogen bond between the HF helix and switch II (T170-D437). Loss of Mg2+ is thought to lead to the weak-ADP state of myosin (Coureux et al., 2004), which is so named due to its low nucleotide affinity that promotes the release of ADP. The subsequent rigor state is stabilized by a new network of hydrogen bonds formed between lysine K169 (HF helix, previously coordinated to the β-phosphate of ADP), and aspartate D437 and isoleucine I438 (switch II).
Upon Mg2+-ADP release, the A-loop also undergoes a small lateral shift (Figure 3B, D and E, Figure 3—video 1C and D). In this way, it likely stabilizes the twisting of the transducer and the N-terminal domain rotation. Surprisingly, the role of the A-loop in both the coordination of ADP and the coupling of the active site to the periphery has not been fully appreciated previously, although it is also involved in nucleotide binding in other myosins (Bloemink et al., 2020). Given their central importance for the coordination of Mg2+-ADP (Figure 1), we propose that the P-loop, the A-loop, and switch I contribute to the sensing of the nucleotide state and its transmission from the nucleotide-binding pocket to the periphery. Their mutual interplay defines the orientation of the N-terminal domain relative to the U50 and L50 subdomains. In this way, small changes in the active site (~1–2 Å) are amplified into significant rotations of the N-terminal and converter domain, eventually leading to a lever arm swing of ~9° upon Mg2+-ADP release (Figure 3, Figure 3—video 1).
Our high-resolution structures of the strong-ADP and rigor state are consistent with the sequential release of Mg2+ and ADP due to the isomerization of myosin to a conformation with reduced nucleotide affinity. In line with this, ADP binding to the rigor state can favor the reversal of this isomerization in the presence of Mg2+.
A similar structural transition upon Mg2+-ADP release has been reported for myosin-IB, -V, and -VI based on medium- and high-resolution cryo-EM structures (Gurel et al., 2017; Mentes et al., 2018; Wulf et al., 2016), suggesting a common coupling mechanism. Although most of the details are intriguingly similar, for example, the remodeling of hydrogen bonds due to the piston movement of the HF helix (Mentes et al., 2018), we find notable differences in the extent of the lever arm swing associated with Mg2+-ADP release (Figure 1—figure supplement 5), as well as the conformation of the relay helix, which partially unwinds in myosin-IB and -VI to allow for the larger lever arm swings (Gurel et al., 2017; Mentes et al., 2018). Interestingly, myosin-IB not only performs a larger lever arm swing (25°) (Mentes et al., 2018), but is also almost 40 times more sensitive to force than myosin-V (9° swing) (Laakso et al., 2008; Veigel et al., 2005). Since load will more easily prevent the isomerization of myosin if Mg2+-ADP release requires a large converter swing, we propose that the force sensitivity, which tunes the kinetics of the transition to the rigor state (Kovács et al., 2007; Laakso et al., 2008; Takagi et al., 2006; Veigel et al., 2005), increases with the extent of the lever arm swing upon Mg2+-ADP release.
AppNHp gives rise to a strongly bound PRT state
We determined the structure of F-actin-myosin-V in complex with the non-hydrolyzable ATP analog AppNHp with the aim to characterize a potentially short-lived, weakly bound state of myosin. The resulting cryo-EM density map shows strong density for AppNHp, indicating high to complete saturation (Figure 4, Figure 4—video 1, Figure 1—figure supplement 3). Interestingly, the density also suggests the presence of two ions, both likely corresponding to Mg2+, given the size of the density and the buffer composition. While one ion occupies approximately the position that Mg2+ takes in the active site of the strong-ADP state, namely close to the γ-phosphate of AppNHp, the other one resides in between the α- and β-phosphates of AppNHp (Figures 1 and 4).
Figure 4. Structure and active site of the aged actomyosin-V complex bound to AppNHp.
(A) Atomic model and LAFTER density map of the central myosin-V-LC subunit (purple, LC: white) bound to aged F-actin-PHD (shades of sea green, three subunits shown, A-1 to A+1). Nucleotides and PHD are highlighted in orange and yellow, respectively. (B) Close-up view of the myosin active site; see Figure 1 for color code. Only side chains involved in the binding of AppNHp are displayed. The density suggests the presence of two Mg2+ ions coordinating the γ, and α- and β-phosphate, respectively; also see Figure 1—figure supplement 3 and Figure 4—video 1. (C) 2D protein-ligand interaction diagram illustrating the coordination of Mg2+-AppNHp by hydrogen bonds (dashed green lines) and hydrophobic interactions (red rays). (D) Illustration of the model-map agreement within a central section of myosin. Most side chains are resolved by the post-refined density map (transparent gray). See Figure 4—figure supplements 1–3 for comparisons of the AppNHp-myosin-V structure with other structures as well as an analysis of unbound myosin in the AppNHp data set.
Figure 4—figure supplement 1. Comparison of AppNHp-bound myosin-V with myosin-V in the rigor and strong-ADP state.
Figure 4—figure supplement 2. Common active site conformation in transition states with weakly bound nucleotide.
Figure 4—figure supplement 3. 2D cryo-EM data of unbound myosin-V in complex with AppNHp.
Figure 4—video 1. Structure of the aged actomyosin-V complex bound to AppNHp.
Similar to ADP, AppNHp is coordinated by a network of hydrogen bonds and additional hydrophobic interactions with the P-loop, switch I, and the A-loop (Figure 1C and Figure 4C). The details of the interactions, however, differ due to the different sizes of the two nucleotides and their relative positions in the active site, that is, the γ-phosphate of AppNHp almost takes the position of the β-phosphate of ADP relative to the HF helix (Figure 4, Figure 1—figure supplement 3, Figure 1).
Surprisingly, and in contrast to a previous low-resolution cryo-EM reconstruction (Volkmann et al., 2005), the overall structure of AppNHp-bound myosin-V is reminiscent of the rigor state (Figure 4—figure supplement 1). In particular, myosin is strongly bound to F-actin and adopts a post-powerstroke lever arm orientation (Figure 4, Figure 4—video 1, Figure 4—figure supplement 1A and B). The active site of AppNHp-bound myosin also closely resembles that of the rigor state, and thereby significantly deviates from the conformation found in the strong-ADP state (Figure 4—figure supplement 1C and D).
The compatibility of an ATP analog, specifically the presence of a γ-phosphate at the active site, with strong F-actin binding is initially puzzling and seemingly at odds with the reported reciprocal nature of these two processes (Coureux et al., 2004; Kühner and Fischer, 2011). A comparison of our AppNHp-bound structure with a rigor-like crystal structure of myosin-V with ADP weakly bound to its active site (Coureux et al., 2004) resolves this conflict (Figure 4—figure supplement 2A). The relative position of AppNHp and ADP in these two structures as well as their coordination, which in particular lacks contacts between K169 of the P-loop and the β-phosphate, is almost identical, suggesting that AppNHp is only weakly bound in our structure and therefore compatible with strong F-actin binding. Interestingly, a similar coordination was observed for Mg2+-ADP in a putative strong-ADP to rigor transition state cryo-EM structure of myosin-IB (Mentes et al., 2018; Figure 4—figure supplement 2B). These comparisons indicate that AppNHp and ADP can both weakly bind to myosin in a conformation reminiscent of the rigor.
Our prior kinetic studies (De La Cruz et al., 1999; Yengo et al., 2002) demonstrated that AppNHp reduces the binding affinity of myosin-V for F-actin by >5000-fold as compared to the rigor state, thus favoring dissociation. A weakened affinity is also supported by the higher concentrations required to achieve decoration of F-actin with myosin in the AppNHp state (see Materials and methods). AppNHp also induces greater structural flexibility in myosin-V (see below) as compared to the rigor state, which may facilitate the transition to a detached state. Based on the presented structural and prior kinetic studies, we propose that our AppNHp-bound myosin-V structure represents a post-rigor transtion (PRT) state that allows to visualize how ATP binds in the rigor state, prior to the transition that involves a switch I movement and promotes detachment of myosin from F-actin. The characteristic weak coordination of AppNHp in the PRT state allows myosin to remain strongly bound to F-actin until a strong coordination of the nucleotide is established. The report of a transition state with weakly bound ADP (Mentes et al., 2018; Figure 4—figure supplement 2B) suggests that weak nucleotide binding is a common scheme and that the PRT state is therefore not limited to AppNHp. The visualization of an ATP analog bound to a state reminiscent of the rigor shows that ATP mainly binds via its adenine ring, as does ADP (Figure 1). It also explains how the γ-phosphate can fit into the relatively small pocket created by the rigor conformation of the P-loop (Figure 4), and how its presence leads to local changes of the active site facilitating a tight coordination (Figure 4—figure supplement 1). In this way, the PRT state provides new insights on how myosin detaches from F-actin and indicates that the theoretical weakly bound post-rigor state (Sweeney and Houdusse, 2010; Walklate et al., 2016) is unlikely to be populated within the motor cycle.
Although we find myosin-V-AppNHp strongly bound to F-actin in the PRT state (Figure 4—figure supplement 1), we had to significantly increase the myosin concentration to achieve full decoration of actin filaments (see Materials and methods for details), in agreement with a weaker binding affinity (Konrad and Goody, 2005; Yengo et al., 2002). We therefore conclude that AppNHp can potentially lead to different structural states, similar to ADP in myosin-IB (Mentes et al., 2018). Likely due to large differences in the binding affinity of these states or rapid detachment of myosin from F-actin, we only find myosin bound to F-actin in the PRT state. In line with this assumption, we find a significant amount of unbound myosin in the background of our AppNHp data sets (Figure 4—figure supplement 3). The 3D reconstruction and thus identification of the structural state of the background myosin were unfortunately impeded by a strong orientational preference of the myosin particles (Figure 4—figure supplement 3B). Further studies are therefore required to test the conformation of AppNHp-bound myosin-V in absence of F-actin.
Conservation and specificity of the actomyosin-V interface
A comparison of the three states of the actomyosin-V complex (strong-ADP, rigor, and PRT state) reveals a striking similarity of the actomyosin interface (Figure 5, Figure 5—video 1). The atomic models superimpose almost perfectly with only little variations in the orientation of some incompletely resolved side chains. The remarkable similarity suggests that the same set of interactions is maintained during all strongly bound states of the myosin motor cycle, despite their varying F-actin-binding affinities. Differences in the affinity might therefore not be linked to altered contacts, but rather to the degree of structural flexibility inherent to each state (see below).
Figure 5. Indistinguishable actomyosin interfaces in the strong-ADP, rigor, and post-rigor transition (PRT) state.
Comparison of the actomyosin-V interface within all three states (rigor: red; strong-ADP: orange; and AppNHp-bound PRT: purple) illustrating the remarkable similarity of interactions with F-actin. (Top) Front and back views of the central myosin molecule and the two actin subunits it is bound to (shades of green and blue, A+1 and A-1; see Figure 1—figure supplement 3 for color code). Black boxes indicate the location of close-up views shown below. (Bottom) Close-up views of all actin-myosin interfaces including the cardiomyopathy (CM) loop, the helix-loop-helix (HLH) motif, loops 2–4, and the activation loop (highlighted by an asterisk). Side chains of key residues are displayed and labeled for all states (rigor: black; ADP and AppNHp: gray). Dashed lines indicate hydrogen bonds predicted for the rigor (black) and ADP/AppNHp state (gray), respectively. See Figure 5—video 1 for a three-dimensional visualization including density maps.
Figure 5—video 1. Conservation of the actomyosin-V interface.
The actomyosin-V interface comprises six structural elements, namely the cardiomyopathy (CM) loop (aa 376–392), loop 4 (aa 338–354), the helix-loop-helix (HLH) motif (505–531), the activation loop (aa 501–504), loop 3 (aa 532–546), and loop 2 (aa 594–635) (Figure 5, Figure 5—video 1). While these elements represent a common set of actin-binding elements, most of which have conserved hydrophobic and electrostatic properties, not all myosins utilize all of them. Moreover, the precise nature of individual interactions and the residues involved varies considerably among myosins, largely due to sequence variations known to tune the kinetic properties of myosin (Mentes et al., 2018; Robert-Paganin et al., 2021). Comparisons of the actomyosin interface of different myosins are therefore essential for identifying common and specific features of the myosin superfamily.
A detailed comparison of the actomyosin interface of myosin-V with previously published actomyosin structures (Banerjee et al., 2017; Behrmann et al., 2012; Doran et al., 2020; Gong et al., 2021; Gurel et al., 2017; Mentes et al., 2018; Risi et al., 2021; Robert-Paganin et al., 2021; Vahokoski et al., 2020; von der Ecken et al., 2016) shows many common features, but also some myosin-V-specific ones. The tightest and most conserved contact is formed by the HLH motif (Robert-Paganin et al., 2021). In analogy to other myosins, it relies primarily on extensive hydrophobic contacts with F-actin, complemented by a series of hydrogen bonds (predicted by PDBsum [Laskowski et al., 2018], Figure 5, Figure 5—video 1E and F). The comparably short CM loop of myosin-V is also highly conserved, with respect to its hydrophobic nature. However, unlike the CM loop of other myosins (Fujii and Namba, 2017; Gurel et al., 2017; Mentes et al., 2018; Risi et al., 2021; von der Ecken et al., 2016), its tip does not engage in complementary electrostatic interactions (Figure 5, Figure 5—video 1C). The conformation we found for loop 4 differs from all others reported so far. Not only is it more compact, folding in a β-hairpin, but it also localizes closer to the base of the CM loop, where it is stabilized by a non-conserved hydrogen bond between C348 and I391 (Figure 5, Figure 5—video 1C). However, its electrostatic interactions with F-actin are reminiscent of those reported for other myosins (Fujii and Namba, 2017; Gurel et al., 2017; Risi et al., 2021; von der Ecken et al., 2016). Loop 2 is exceptionally long in myosin-V and only partially resolved in our structures (Figure 5—video 1). While this is also the case for most actomyosin structures resolved so far (Banerjee et al., 2017; Doran et al., 2020; Gong et al., 2021; Risi et al., 2021; Robert-Paganin et al., 2021; von der Ecken et al., 2016), loop 2 of myosin-V stands out by the unique α-helical fold of its C-terminal part (Figure 5—video 1I). This fold facilitates a compact packing of basic residues and thereby promotes the electrostatic interactions commonly found at the loop 2 interface. The activation loop is a structural element that does not contribute to F-actin binding in all myosins (Gurel et al., 2017; Robert-Paganin et al., 2021). In myosin-V, it forms primarily electrostatic interactions with the N-terminus of F-actin, but does not lead to its ordering, as has been reported for other myosins (Figure 5, Figure 5—video 1E; Banerjee et al., 2017; Behrmann et al., 2012; Fujii and Namba, 2017; Mentes et al., 2018; Vahokoski et al., 2020). The last structural element involved in actin binding is loop 3. It forms the so-called Milligan contact (Milligan et al., 1990), which is strong in myosin-V and includes electrostatic and hydrophobic interactions as well as several hydrogen bonds (Figure 5, Figure 5—video 1H). The contact is furthermore strengthened by hydrogen bonds between K540-N545 and S544-K546 that stabilize the conformation of loop 3. Interestingly, a strong Milligan contact has also been reported for myosin-IB and -VI (Gurel et al., 2017; Mentes et al., 2018), whereas no or only weak interactions were found in class II myosins (Doran et al., 2020; Fujii and Namba, 2017; Risi et al., 2021; von der Ecken et al., 2016). We therefore speculate that an intimate Milligan contact might be a general feature of myosins with long actin-attachment lifetimes and high binding affinities for F-actin and ADP, allowing them to bind particularly tightly to fulfill their function as cargo transporters or molecular anchors.
In summary, we demonstrated that myosin-V establishes a maximum of contacts with F-actin, utilizing all six potential binding elements (Figure 5, Figure 5—video 1E and F). In addition, we have identified a previously unseen α-helical fold of the C-terminus of loop 2 (Figure 5, Figure 5—video 1I), which possibly strengthens the interactions at this interface.
Myosin-V specifically selects the closed D-loop conformation of F-actin
To assess the structural effect of myosin binding on F-actin, we compared the structure of aged F-actin-PHD in the presence (rigor state, representative for all states) and absence of myosin-V (PDB: 6T20; Pospich et al., 2020; Figure 6). The observed differences are subtle and primarily involve the DNase-binding loop (D-loop, aa 39–55) of F-actin and loops known for their flexibility (Pospich et al., 2020). The most prominent alteration involves glutamine Q49 within the D-loop, which moves away from the actomyosin interface by ~2 Å to enable the formation of a hydrogen bond with N529 in the HLH motif of myosin (Figure 5 and Figure 6). Similar, but not identical, subtle changes have been reported for other actomyosins (Behrmann et al., 2012; Gong et al., 2021; Gurel et al., 2017; Robert-Paganin et al., 2021; von der Ecken et al., 2016), in addition to an ordering of the N-terminus of actin (Banerjee et al., 2017; Behrmann et al., 2012; Fujii and Namba, 2017; Mentes et al., 2018; Vahokoski et al., 2020; von der Ecken et al., 2016), which we do not observe for myosin-V.
Figure 6. Myosin binding gives rise to subtle structural changes of aged PHD-stabilized F-actin.
Illustration of the structural similarity of aged F-actin-PHD in the absence and presence of myosin. (A) Atomic model of aged F-actin-PHD (PDB: 6T20; Pospich et al., 2020; three subunits shown, A-1 to A+1) color-coded by the backbone root mean square deviation (RMSD) of this structure with the one of aged F-actin-PHD decorated with myosin-V in the rigor state. (B) Close-up view of the D-loop interface illustrating that the structural changes associated with myosin binding are small. For a direct comparison, the atomic model of the rigor actomyosin-V complex is superimposed (transparent gray). F-actin subunits were aligned individually to account for errors in the calibration of the pixel size. (C) Comparison of LAFTER density maps of aged F-actin-PHD on its own (blue mesh) and bound to myosin-V (gray). For guidance, the atomic model of F-actin-PHD colored by RMSD is also shown. See Table 5 for a comparison of helical symmetry parameters.
Notably, our data show no significant change of the helical symmetry parameters upon myosin binding, neither in rigor nor in any other state of myosin (Table 5). This is in stark contrast to an earlier medium-resolution study of myosin-V, which reported additional twisting of PHD-stabilized F-actin dependent upon the nucleotide state of myosin (Wulf et al., 2016).
Table 5. Summary of helical symmetry parameters.
Rise (Å) | Twist (°) | Pixel size (Å) | |
---|---|---|---|
Helical symmetry | |||
Aged F-actin-PHD+ rigor | 27.82±0.02 | –167.27±0.02 | 1.06 |
Aged F-actin-PHD+ ADP | 27.81±0.02 | –167.32±0.02 | 1.06 |
Aged F-actin-PHD+ AppNHp | 27.77±0.02 | –167.32±0.02 | 1.10 |
Aged F-actin-PHD (PDB: 6T20) | 27.59±0.02 | –166.9±0.1 | 1.14 |
Young F-actin-JASP | 27.85±0.08 | –166.87±0.02 | 1.10 |
Young F-actin-JASP+ Rigor | 27.72±0.01 | –167.06±0.02 | 1.10 |
Young F-actin-JASP (PDB: 5OOD) | 27.39 | –166.41 | 1.09 |
It was reported that myosin-V is sensitive to the nucleotide state of F-actin and prefers young PHD-stabilized F-actin over aged F-actin-PHD (Zimmermann et al., 2015). We have recently shown that young ATP/ADP-Pi-bound and aged ADP-bound F-actin primarily differ in their conformation of the D-loop-C-terminus interface and that actin-binding proteins like coronin-IB (Cai et al., 2007) probably recognize the nucleotide state of F-actin from this interface (Merino et al., 2018). We have furthermore shown that the short-lived ATP/ADP-Pi-bound state of F-actin can be specifically stabilized using either PHD (Lynen and Wieland, 1938) or jasplakinolide (JASP) (Crews et al., 1986; Pospich et al., 2020). To reveal the structural mechanism by which myosin-V senses the nucleotide state of F-actin, we have solved the structure of myosin-V in the rigor state in complex with young JASP-stabilized F-actin (F-actin-JASP) to 3.2 Å (referred to as young actomyosin-V, Figure 7, Table 6, Figure 7—figure supplement 1, Figure 1—figure supplement 1, Table 1). The atomic model of myosin in this structure superimposes perfectly with the one bound to aged F-actin-PHD (Figure 7C and D), indicating that the nucleotide state of F-actin has no structural effect on myosin-V in the rigor state. Surprisingly, and despite having ADP-Pi bound to its active site (Figure 1—figure supplement 3), F-actin adopts the closed D-loop state, which is characteristic for aged ADP-bound F-actin (Figure 7; Merino et al., 2018). However, a control structure of F-actin-JASP alone (3.1 Å, Figure 7—figure supplement 1, Table 1, Table 6, Figure 1—figure supplement 1) confirms that actin was successfully stabilized in the desired young state, having a characteristic open D-loop conformation (Figure 7—figure supplement 2) and ADP-Pi bound to its active site (Figure 1—figure supplement 3). Thus, we conclude that binding of myosin-V to young F-actin-JASP induces structural changes that ultimately result in the closed D-loop conformation (Figure 8, Figure 8—video 1, Figure 8—figure supplement 1), thereby abolishing the effect of JASP (Pospich et al., 2020). Interestingly, our data show that the open D-loop state would not clash with bound myosin (Figure 8C and D). The closed conformation may therefore be selected for its superior shape complementarity to myosin, which possibly establishes a strong binding interface between the D-loop and HLH motif and by doing so contributes to the high-binding affinity of the rigor state (Figure 8).
Figure 7. Structure of the young actomyosin-V complex in the rigor state.
(A) Atomic model and LAFTER density map of the central myosin-V-LC subunit (red, LC: white) bound to young F-actin-JASP (shades of blue, three subunits shown, A-1 to A+1). Nucleotides and JASP are highlighted in orange and yellow, respectively; also see Figure 8—video 1F–H. (B) Illustration of the model-map agreement within a central section of myosin. Most side chains are resolved by the post-refined density map (transparent gray). (C) Superposition and (D) color-coded root mean square deviation (RMSD) of the young and aged actomyosin-V complex in the rigor state illustrating their structural identity. Residues with increased RMSD solely localize to regions of lower local resolution and can therefore be explained by modeling inaccuracies. See Figure 7—figure supplement 1 and Table 6 for an overview of the cryo-EM data and refinement and model building statistics, respectively. The structure of young F-actin-JASP in the absence of myosin is shown in Figure 7—figure supplement 2.
Figure 7—figure supplement 1. Overview of the cryo-EM data and resolution of young F-actin-JASP alone and in complex with myosin-V in the rigor state.
Figure 7—figure supplement 2. Structure of young JASP-stabilized F-actin.
Table 6. Statistics of young actomyosin in the rigor state.
Young F-actin-JASP | Rigor state: young F-actin-JASP + myosin-Va-LC | |||||
---|---|---|---|---|---|---|
Actin only3er/2er | Central 3er/2er | Central 1er(subtracted) | Class 1 | Class 2 | Class 4 | |
3D refinement statistics | ||||||
Number of helical segments | 212,660 | 414,148 | 414,148 | 110,797 | 107,022 | 107,174 |
Resolution (Å) | 3.1 | 3.2 | 3.2 | 3.6 | 3.5 | 3.6 |
Map sharpening factor (Å2) | –56 | –83 | –50 | –55 | –49 | –54 |
Atomic model statistics | ||||||
Non-hydrogen atoms | 8940 | 23,278 | 10,149 | 10,169 | 10,169 | 10,156 |
Cross-correlation masked | 0.81 | 0.84 | 0.83 | 0.84 | 0.83 | 0.83 |
MolProbity score | 1.27 | 1.29 | 1.15 | 1.24 | 1.26 | 1.23 |
Clashscore | 5.11 | 5.46 | 3.62 | 4.66 | 4.91 | 4.57 |
EMRinger score* | 3.11/3.08 | 2.92/2.66 | 3.11/2.92 | 2.89/2.96 | 2.99/3.39 | 2.88/2.55 |
Bond RMSD (Å) | 0.004 | 0.004 | 0.009 | 0.005 | 0.003 | 0.004 |
Angle RMSD (°) | 0.915 | 0.780 | 0.950 | 0.836 | 0.807 | 0.835 |
Rotamer outliers (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Ramachandran favored (%) | 100.00 | 99.86 | 99.84 | 99.84 | 99.84 | 99.84 |
Ramachandran outliers (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CaBLAM outliers (%) | 0.27 | 0.75 | 0.90 | 0.81 | 0.65 | 0.49 |
Values correspond to score against the post-refined map used for real-space refinement/a map filtered to local resolution.
Figure 8. Myosin-V binding causes closure of the D-loop in young JASP-stabilized F-actin.
(A) Atomic model and LAFTER density map of young F-actin-JASP (shades of blue, subunits A-1 and A+1). Before myosin binding, the D-loop primarily adopts the open conformation and the C-terminus is extended. A superimposed atomic model (gray) highlights a minor density potentially corresponding to the closed D-loop conformation. (B) Binding of myosin-V in the rigor state (red) causes a structural transition to the closed D-loop conformation, which comes with an α-helical C-terminus; also see Figure 8—video 1 and Figure 8—figure supplement 1. (C) Surface representation of young F-actin-JASP (open D-loop, as shown in A) illustrating that the open D-loop conformation would not clash with myosin (computationally docked). (D) Surface representation of the young JASP-stabilized actomyosin complex (closed D-loop, as shown in B). See Figure 8—figure supplement 2 for an illustration how pyrene labeling might interfere with myosin binding.
Figure 8—figure supplement 1. Myosin-V selects a specific conformation of F-actin.
Figure 8—figure supplement 2. Pyrene labeling potentially impedes selection of the closed D-loop.
Figure 8—video 1. Structural changes of JASP-stabilized F-actin upon binding of myosin-V.
Our structure does not provide a structural explanation for the reported nucleotide-sensitivity of myosin-V (Zimmermann et al., 2015). This could be due to three, possibly complementary, reasons. First, myosin-V might be sensitive to the nucleotide state of F-actin only in certain structural states, such as the initially binding PPS (Wulf et al., 2016) and PiR states (Llinas et al., 2015). Second, the structural plasticity of young ATP/ADP-Pi-bound F-actin (Kueh and Mitchison, 2009), rather than the open D-loop conformation, might be beneficial for myosin binding. Third, the open D-loop conformation might promote the formation of initial contacts with myosin-V. Once these are established, the subsequent transition from a weak- to a strong binding state potentially causes a structural transition of F-actin, eventually locking it in the closed D-loop conformation. In line with these theories, a number of biochemical and biophysical studies suggested that a structural rearrangement of F-actin and its structural plasticity are critical for proper myosin activity (Anson et al., 1995; Drummond et al., 1990; Kim et al., 2002; Nishikawa et al., 2002; Noguchi et al., 2012; Oztug Durer et al., 2011; Prochniewicz and Thomas, 2001; Prochniewicz et al., 2010). Moreover, the D-loop C-terminus interface was predicted to contribute to the initial binding interface of myosin (Gurel et al., 2017; Lehman et al., 2013; Risi et al., 2017; Robert-Paganin et al., 2020).
Finally, the conformational selection mechanism of myosin-V offers a structural explanation for the quenching of pyrene fluorescence upon myosin binding. Pyrene conjugated to cysteine 374 in the C-terminus of F-actin has been often used to report not only actin kinetics, but also myosin binding (Kouyama and Mihashi, 1981). Closure of the actin-binding cleft of myosin is thought to expose pyrene to the solvent and thus cause fluorescence quenching (Chou and Pollard, 2020), but the exact timing and the structural basis are not yet known (Llinas et al., 2015; Robert-Paganin et al., 2020). A recent cryo-EM structure of pyrene-labeled F-actin has revealed that pyrene wedges itself between the tip of the D-loop and the hydrophobic groove surrounding it, partially pushing the D-loop out of its binding pocket (Chou and Pollard, 2020). This likely interferes with myosin selecting the closed D-loop state (Figure 8—figure supplement 2). We furthermore suggest that myosin quenches the fluorescence of pyrene by pushing it out of its binding pocket when selecting the closed D-loop state during its transition to a strong binding state.
Pronounced structural heterogeneity of myosin-V
To identify a potential mixture of structural states, we performed 3D classifications of signal-subtracted particles for all our data sets (Figure 1—figure supplement 1). Interestingly, the results indicate a continuous conformational heterogeneity of myosin-V as opposed to a mixture of several discrete structural states (see Materials and methods for details). Based on the identified 3D classes, we solved and modeled a total of 18 high-resolution (<3.7 Å) structures of actomyosin-V (Figure 1—figure supplement 1, Table 2, Table 3, Table 4 and Table 6). A superposition of all structures from one data set illustrates pronounced structural flexibility of all domains, but the L50 domain, F-actin, and the actomyosin interface (Figure 9, also see Figure 5). Primarily, the U50 domain pivots and moves toward or away from the actin interface, resulting in twisting and shifting of the central transducer β-sheet, which is coupled to rotations of the N-terminal and the converter domain (Figure 9A). In this way, pivoting of the U50 domain leads to different lever arm positions within the 3D classes of a single data set (Figure 9A, Figure 9—video 1, Figure 9—video 2, Figure 9—video 3). The extent (~9–12°) of the relative lever arm swings is intriguing (Figure 9A, Figure 9—figure supplement 1), considering that the swing associated with Mg2+-ADP-release is only ~9° for myosin-V (Figure 3).
Figure 9. Conformational heterogeneity of myosin-V.
Illustration of the conformational heterogeneity of myosin-V in the rigor (red), strong-ADP (orange), and AppNHp-bound post-rigor transition (PRT) state (purple) when bound to F-actin (aged F-actin-PHD: sea green; young F-actin-JASP: blue). (A) Superposition of all atomic models (central 1er, average: opaque; 3D classes: transparent) built for each state. Models were either aligned on the F-actin subunit or the HF helix (indicated by black arrowhead). Pivoting of the U50 domain in combination with shifting and twisting of the central transducer β-sheet results in a rotation of the N-terminal and converter domain, giving rise to a two-dimensional distribution of lever arm orientations. The extent of these changes depends on the nucleotide state and is largest in the strong-ADP and PRT state. Insets show either the transducer β-sheet (black dot) or the active site (asterisk), which basically remains unchanged within all models of one state. (B) Mapping of atomic models (average and 3D classes) into the first two principal components of a principal component analysis (PCA) illustrating the overall conformational space covered. Classes are labeled by their number (#1–#8; also see Figure 1—figure supplement 1). For a comparison of conformational extremes, see Figure 9—figure supplement 1. Morphs of extremes and trajectories along the principal components are visualized in Figure 9—video 1, Figure 9—video 2, and Figure 9—video 3. See Figure 1—figure supplement 6 for an overview of the domain architecture of myosin.
Figure 9—figure supplement 1. Extreme conformations of myosin-V.
Figure 9—video 1. Structural heterogeneity of myosin-V in the strong-ADP state.
Figure 9—video 2. Structural heterogeneity of myosin-V in the rigor state.
Figure 9—video 3. Structural heterogeneity of myosin-V in the post-rigor transition (PRT) state (AppNHp).
Our data show that the conformational heterogeneity of myosin-V is not caused by variations of the active site or mixed nucleotide states (Figure 9). Nevertheless, the presence of a nucleotide does affect the extent of flexibility as ADP and AppNHp lead to a greater change in lever arm position (Figure 9A). This tendency is also reflected by the size of the respective conformational spaces when mapping all models belonging to one data set onto their principal components (PCs) using principal component analysis (PCA) (Figure 9B).
To impartially compare the conformations of the different nucleotide states of myosin-V, we performed a PCA of all models (Figure 10). The structural similarity and differences of the atomic models are well reflected by their localization within the PC space as well as their corresponding conformational spaces (Figure 10A). Notably, the significantly larger conformational space of the AppNHp data indicates a considerable difference to the rigor state, supporting our proposal of a PRT state. The fact that the conformational spaces of the strong-ADP and rigor state do not overlap is anticipated, given that we have oversaturated myosin with Mg2+-ADP (see Materials and methods).
Figure 10. Principal component analysis of all myosin-V models.
Principal component analysis of all atomic models of the actomyosin-V complex, including average and 3D class average models of the strong-ADP, rigor, and post-rigor transition (PRT) state (central actomyosin subunit only). (A) Mapping of atomic models into the first and second as well as the second and third principal components. Data points are colored by the state of the actomyosin-V complex (aged rigor: red; aged strong-ADP: orange; aged AppNHp-bound PRT: purple; and young rigor: blue). Atomic models of average structures are shown as opaque, and models of 3D classes as transparent. The conformational space covered within each state is indicated by a correspondingly colored 2D polygon. (B) Superposition of all lever arm positions reflecting the relative mapping of individual conformational spaces. Changes along the first and third principal components are highlighted by black and gray arrows, respectively (extremes marked with asterisks). (C) Color-coded trajectories along the first, second, and third principal components (red minimum, blue maximum). Arrows indicate the mapped conformational changes. (D) Same views as in (C) but showing the extreme structures along each principal component; see Figure 9 for color code. For an animation of trajectories and morphs of the extreme structures, see Figure 10—video 1; and see Figure 1—figure supplement 6 for an overview of the domain architecture of myosin.
Figure 10—video 1. Structural heterogeneity of myosin-V: principal component analysis (PCA) of all atomic models.
The conformational changes mapped on each PC are readily illustrated by their corresponding trajectories as well as the extreme structures along each PC (Figure 10C, Figure 10—video 1). The motions along the first and second PCs correspond to an almost perpendicular pivoting of the U50 domain, causing a twist and shift of the central transducer β-sheet and ultimately rotations of the N-terminal and converter domain. The third PC maps a rotation of the N-terminal and converter domain around the transducer, which acts as a hinge region. Since all average structures localize close to the origin of PC 3 (Figure 10A, Figure 10—video 1E and F), we suggest that this PC accounts for an inherent flexibility of the transducer β-sheet.
The rearrangements, especially along the first PC, are reminiscent of the structural transition of myosin-V upon Mg2+-ADP release (Figures 3 and 10C, Figure 10—video 1). In line with this, we find the strong-ADP and rigor average structures to be arranged diagonally within the PC 1–PC 2 space (Figure 10A). This indicates that the conformational heterogeneity of myosin-V as well as the isomerization associated with Mg2+-ADP release relies on the same principal coupling mechanism. Furthermore, this suggests that the structural transition of myosin-V along its motor cycle is driven, at least in part, by its conformational flexibility. Based on this, we therefore propose that the active site of myosin-V is not mechanically, and thus rigidly, coupled to the surrounding domains, particularly the lever arm, as previously proposed (Fischer et al., 2005). Rather, its coupling seems to be statistical in nature, ultimately leading to a thermodynamic ensemble of conformations within each state. The associated structural flexibility of myosin-V possibly initiates transitions between structural states by giving rise to short-lived intermediate conformations with favorable nucleotide-binding affinities. Interactions with a nucleotide would consequently not trigger the transition, but merely stabilize myosin in its transient conformation, thereby promoting the transition to a new structural ensemble state.
A non-rigid, stochastic coupling of the active site of myosin-V is in good agreement with the release of Mg2+-ADP due to an isomerization as well as the existence of the PRT state. It also provides a good explanation for the different binding affinities of the rigor and strong-ADP state. Specifically, we propose that the extent of conformational heterogeneity tunes the binding affinity rather than changes in the actomyosin interface since these are almost the same in all three nucleotide states studied (Figure 5). Restrictions of the conformational space by external forces, that is, load on the lever arm, could account for the load dependence of transitions within the cycle, such as the delay of ADP release under load (Mentes et al., 2018).
The conformational flexibility we observe (Figures 9 and 10) as well as our conclusions on its role in the motor cycle are in line with more than two decades of molecular spectroscopy experiments, which have primarily, but not exclusively, studied myosin-II. In particular, site-directed labeling has demonstrated that myosin is highly dynamic and that multiple, functionally relevant structural states coexist within a single biochemical state (Forkey et al., 2003; Nesmelov et al., 2008; Nesmelov et al., 2011; Thomas et al., 2009). Moreover, it was shown that neither the active site is tightly coupled to the structural domains of the motor nor are the domains themselves (Klein et al., 2008; Korman et al., 2006; Naber et al., 2010; Sun et al., 2006). Our results extend the spectroscopic data, which have already elucidated conformational amplitudes and kinetics, by directly visualizing the dynamics of myosin as well as the underlying molecular coupling.
While the agreement of our results with the spectroscopic data on myosin-II (Thomas et al., 2009) already suggests that statistical coupling and conformational flexibility are general features of the myosin superfamily, rather than a hallmark of myosin-V, there are additional independent indications. On the one hand, statistical coupling of the active site has also been proposed for myosin-VI based on a recovery stroke intermediate crystal structure, showing that the lever arm can partially re-prime while the active site remains unchanged (Blanc et al., 2018). On the other hand, conformational heterogeneity has also been reported for myosin-IE and -IB based on either crystal structures or cryo-EM data of the actomyosin complex (Behrmann et al., 2012; Kollmar et al., 2002; Mentes et al., 2018). Notably, a flexibility reminiscent of the one observed for myosin-V (Figures 9 and 10) was reported for myosin-IE in the rigor state (Behrmann et al., 2012). Conversely, no flexibility was described for myosin-IB, which adopts a single state in the absence of a nucleotide and two discrete states when bound to Mg2+-ADP (Mentes et al., 2018). Whether these results reflect properties of specific myosins or rather current limitations of data analysis methods, for example, number of particles, low signal-to-noise ratio, robustness of 3D classifications (Pospich and Raunser, 2018), remains to be investigated. In general, there is little structural data on the conformational dynamics of myosin as most structures originate either from small cryo-EM data sets, which have an insufficient number of particles for extensive 3D classifications, or from X-ray crystallography. We therefore believe that the structural characterization of myosin’s dynamic landscape will provide novel insights into the details of force generation.
Summary
The presented high-resolution cryo-EM structures of the actomyosin-V complex in three nucleotide states—nucleotide-free, Mg2+-ADP, and Mg2+-AppNHp (Table 1)—provide valuable insights into the structural basis of force generation. First, a comparison of the strong-ADP (Figure 1) and rigor state (Figure 2) has revealed the structural transition of myosin-V upon Mg2+-ADP-release (Figure 3), which is reminiscent of the one of myosin-IB (Mentes et al., 2018) and yet differs in its details. Second, the structure of Mg2+-AppNHp-bound myosin-V has uncovered a previously unseen post-rigor transition (PRT) state (Figure 4), which is strongly bound to F-actin and adopts a conformation resembling the rigor state. Because of the weak binding to the active site, AppNHp, and probably ATP, does not directly trigger the detachment from F-actin and thus the transition to the post-rigor state. Instead, strong nucleotide binding likely needs to be established to eventually initiate detachment.
Interestingly, and despite the differences in the F-actin-binding affinity, we find that the actin-binding interface is basically indistinguishable in all three nucleotide states (Figure 5), suggesting that strongly bound states utilize a common binding scheme. Furthermore, a comparison of the interface with the one of other myosins has revealed specific features of the myosin-V interface and indicates that a strong Milligan contact (Milligan et al., 1990) is characteristic of myosins with long lifetimes of actin-bound states and high binding affinities for ADP and F-actin, as found in high duty-ratio myosins and myosin-IB (Laakso et al., 2008; Lewis et al., 2006).
In contrast to previous reports (Wulf et al., 2016), our results elucidate that myosin-V hardly alters the structure of aged F-actin-PHD (Figure 6). Conversely, it has a remarkable effect on the structure of young F-actin-JASP, specifically selecting the closed D-loop state (Figures 7 and 8) and thereby overriding the ‘rejuvenating effect’ of JASP (Merino et al., 2018; Pospich et al., 2020). Whilst this result does not reveal the structural basis of myosin-V’s nucleotide sensitivity (Zimmermann et al., 2015), it offers an explanation for pyrene fluorescence quenching upon myosin binding (Kouyama and Mihashi, 1981).
Additional heterogeneity analysis of our data revealed a pronounced structural flexibility of myosin-V (Figures 9 and 10), indicating a non-rigid, stochastic coupling of the active site. While the extent of flexibility is altered by the presence of a nucleotide, structural transitions of myosin-V are likely not initiated by binding of a specific nucleotide, but rather by thermodynamic fluctuations, as previously suggested for myosin-VI (Blanc et al., 2018).
Taken together, we have elucidated many, previously unknown details of the force generation mechanism. The general validity of these results, that is, if they are limited to myosin-V or hold for the complete myosin superfamily, as well as the possible implications of our findings has to be thoroughly tested in future studies. Structural data on how actin activates myosin and how myosin eventually detaches will surely be of interest (Robert-Paganin et al., 2020; Schröder, 2020; Sweeney et al., 2020). Yet, great insights could also come from the structural characterization of myosin’s dynamic landscape. Finally, unraveling the structural basis of nucleotide sensitivity (Zimmermann et al., 2015) will further promote our understanding of the regulation of both myosin and the actin cytoskeleton (Merino et al., 2020).
Materials and methods
Key resources table.
Reagent type (species) or resource | Designation | Source or reference | Identifiers | Additional information |
---|---|---|---|---|
Gene (Gallus gallus) | MYO5A | De La Cruz et al., 1999 | Uniprot ID:Q02440 | Unconventional myosin-Va |
Gene (Homo sapiens) | MYL6B (MLC1SA) | De La Cruz et al., 1999 | Uniprot ID:P14649 | Myosin light chain 6B/myosin LC 1 – slow-twitch muscle A isoform |
Cell line (Spodoptera frugiperda) | SF9 cells | De La Cruz et al., 1999 | Insect cells, for baculovirus expression | |
Biological sample (Oryctolagus cuniculus) | Rabbit skeletal muscle acetone powder | Gift from W. Linke and A. Unger (Ruhr-Universität Bochum, Germany) | N/A | For purification of α-actin (Uniprot ID:P68135) |
Recombinant DNA reagent | pVL1392 pVL1393(plasmids) | De La Cruz et al., 1999 | Invitrogen, V1392-20 | |
Chemical compound, drug | Phalloidin (PHD)Amanita phalloides | Sigma-Aldrich | P2141 | For stabilization of aged ADP-bound F-actin |
Chemical compound, drug | Jasplakinolide (JASP) | Sigma-Aldrich | J4580 | For stabilization of young ADP-Pi-bound F-actin |
Chemical compound, drug | AppNHp (AMPPNP) | Jena Bioscience | NU-407-10 | |
Chemical compound, drug | ADP | Sigma-Aldrich | A2754 | |
Software, algorithm | TranSPHIRE | Stabrin et al., 2020; PMID:33177513 | v1.4–1.5.7 | |
Software, algorithm | MotionCor2 | Zheng et al., 2017; PMID:28250466 | v1.1.0; v1.3.0; v1.2.6 | Within TranSPHIRE |
Software, algorithm | GCTF | Zhang, 2016; PMID:26592709 | v1.06 | Within TranSPHIRE |
Software, algorithm | crYOLO | Wagner et al., 2020; PMID:32627734 | v1.2.2; v1.2.4; v1.4.1 | Within TranSPHIRE |
Software, algorithm | GPU-ISAC | Stabrin et al., 2020; PMID:33177513 | v1.2 and earlier | Within TranSPHIRE |
Software, algorithm | Cinderella | Stabrin et al., 2020; PMID:33177513 | v0.3.1 | Within TranSPHIRE |
Software, algorithm | SPHIRE | Moriya et al., 2017; PMID:28570515 | v1.3 | Helical processing pipeline, including CTF refinement and signal subtraction |
Software, algorithm | Relion | Scheres, 2012; PMID:23000701 | v3.0.4 | For particle polishing and 3D classifications |
Software, algorithm | UCSF Chimera | Pettersen et al., 2004; PMID:15264254 | v1.15 | |
Software, algorithm | UCSF ChimeraX | Goddard et al., 2018; PMID:28710774 | v0.91 | For model building with ISOLDE |
Software, algorithm | ISOLDE | Croll, 2018; PMID:29872003 | v1.0b4 | |
Software, algorithm | Coot | Emsley et al., 2010; PMID:20383002 | v0.8.9.2 | |
Software, algorithm | Phenix | Adams et al., 2011; Afonine et al., 2018; PMID:18094468 | v1.17.1 | |
Software, algorithm | elBOW | Moriarty et al., 2009; PMID:19770504 | v1.17.1 | Within Phenix |
Software, algorithm | MolProbity | Chen et al., 2010; PMID:20057044 | v1.17.1 | Within Phenix |
Software, algorithm | EMRinger | Barad et al., 2015; PMID:26280328 | v1.17.1 | Within Phenix |
Software, algorithm | LAFTER | Ramlaul et al., 2019; PMID:30502495 | v1.1 | |
Software, algorithm | Bio3d | Grant et al., 2006; PMID:32734663 | v2.3-4 | Library for PCA in R |
Software, algorithm | DynDom | Hayward and Lee, 2002; PMID:12463636;http://dyndom.cmp.uea.ac.uk | Accessed October 2020 | |
Software, algorithm | PDBsum | Laskowski et al., 2018; PMID:28875543;https://www.ebi.ac.uk/pdbsum/ | Accessed November 2020 | |
Other | Cryo-EM grids | Quantifoil (QF) | R2/1 300 mesh |
Protein expression and purification
Actin was purified from rabbit skeletal muscle acetone powder by cycles of polymerization and depolymerization as described previously (Merino et al., 2018; Pardee and Spudich, 1982; Pospich et al., 2020). Purified G-actin was flash-frozen and stored in G-actin buffer (5 mM Tris pH 7.5, 1 mM DTT, 0.2 mM CaCl2, 2 mM NaN3, and 0.5 mM ATP) at –80°C.
Myosin V was expressed using the baculovirus/SF9 cell expression system. To create the recombinant virus used for expression, the cDNA coding for chicken myosin-Va was truncated after the codon corresponding to Arg792. This construct encompassed the motor domain and the first light chain/calmodulin-binding site of myosin-Va. A ‘Flag’ tag DNA sequence (encoding GDYKDDDDK) (Hopp et al., 1988) was appended to the truncated myosin-V coding sequence to facilitate purification. A truncated cDNA for the LC1-sa light chain (De La Cruz et al., 2000) was coexpressed with the truncated myosin-V heavy chain in SF9 cells as described in De La Cruz et al., 1999. The cells were grown for 72 hr in medium containing 0.2 mg/ml biotin, harvested and lysed by sonication in 10 mM imidazole, pH 7.4, 0.2 M NaCl, 1 mM EGTA, 5 mM MgCl2, 7% (w/v) sucrose, 2 mM DTT, 0.5 mM 4-(2-aminoethyl)benzenesuflonyl fluoride, 5 μg/ml leupeptin, and 2 mM MgATP. An additional 2 mM MgATP was added prior to a clarifying spin at 200,000 × g for 40 min. The supernatant was purified using FLAG-affinity chromatography (Sigma). The column was washed with 10 mM imidazole pH 7.4, 0.2 M NaCl, and 1 mM EGTA, and the myosin eluted from the column using the same buffer plus 0.1 mg/ml FLAG peptide. The fractions containing myosin were pooled and concentrated using an Amicon centrifugal filter device (Millipore) and dialyzed overnight against F-actin buffer (10 mM HEPES pH 7,5, 100 mM KCl, 2 mM MgCl2, 1 mM DTT, and 1 mM NaN3). Purified myosin-V-LC was flash-frozen and stored at –80°C.
Sample preparation for cryo-EM
Aliquots of G-actin were freshly thawed and cleared by ultracentrifugation (Beckmann Rotors, TLA 120.1, 100.000 × g, 1 hr, 4°C). The concentration of G-actin was measured by absorption spectroscopy (Spectrophotometer DS-11, DeNovix, E290 nm ≈ 22,000 M–1 cm–1 at 290 nm; Hertzog and Carlier, 2005). Polymerization was induced by adding 100 mM KCl, 2 mM MgCl2, and 0.5 mM ATP. In case of young JASP-stabilized F-actin, actin was polymerized in the presence of a 2× molar excess of JASP (Sigma-Aldrich, freshly solved in DMSO, 1 mM stock). After 2 hr of incubation at room temperature, the sample was transferred to 4°C for further polymerization overnight. Filaments were collected by ultracentrifugation (Beckmann Rotors, TLA 120.1, 100.000 × g, 2 hr, 4°C) and pellets rinsed and resuspended in F-actin buffer (10 mM HEPES pH 7.5, 100 mM KCl, 2 mM MgCl2, 1 mM DTT, 1 mM NaN3) supplemented with 0.02 w/v% Tween 20 (to improve spreading of the sample droplet on the cryo-EM grid). No additional ADP or JASP was added. In case of aged PHD-stabilized F-actin, a 2× molar excess of PHD (Sigma-Aldrich, freshly solved in methanol, 1.25 mM stock) was added to resuspended filaments, which have aged, that is, hydrolyzed ATP and released the inorganic phosphate, during the overnight polymerization step. Filaments were stored at 4°C for a few hours before preparation of cryo-EM grids.
Aliquots of myosin-V-LC were freshly thawed, diluted 1:1 with F-actin buffer, and cleared by centrifugation (Eppendorf centrifuge 5424R, 21,000 × g, 5 min, 4°C). The concentration was determined by absorption spectroscopy (Spectrophotometer DS-11, DeNovix, E280 nm ≈ 106,580 M–1 cm–1 at 280 nm).
Cryo-EM grid preparation and screening
To avoid bundling of actomyosin filaments, F-actin was decorated with myosin-V-LC on the grid, as described previously (von der Ecken et al., 2016). A freshly glow-discharged holey-carbon grid (QF R2/1 300 mesh, Quantifoil) was mounted to a Vitrobot cryoplunger (Thermo Fisher). 3 µl of F-actin (3–4 µM) were applied onto the front of the grid and incubated for 60 s. Excess solution was manually blotted from the side using blotting paper (Whatman No. 4). Immediately, 3 µl of myosin-V-LC (3–13 µM) were applied onto the grid and incubated for 30 s. The grid was automatically blotted for 9 s (blot force –15 or –25, drain time 0–1 s) and plunged into liquid ethane. The temperature was set to 13°C for all samples but the AppNHp sample, where either 4 or 25°C were used (two settings and data sets, see Table 1).
Myosin was kept in F-actin buffer and was only diluted and supplemented with a nucleotide and Tween 20 immediately before application to the grid to avoid any adverse effects. When preparing the strong-ADP state, myosin was diluted 1:1 in a 2× ADP buffer (F-actin buffer with 40 mM MgCl2, 4 mM ADP, and 0.04 w/v% Tween 20). For the rigor samples, myosin was diluted in F-actin buffer supplemented with 0.02 w/v% Tween 20. AppNHp-bound samples were prepared in analogy to rigor samples, but additional 5 mM AppNHp and 4 mM MgCl2 were added. As AppNHp hydrolyzes spontaneously, only freshly solved (10 mM HEPES pH 8.0, 1 mM DTT, 1 mM NaN3, and 2 mM MgCl2) or recently frozen AppNHp was used. Ion-pair reversed-phase chromatography experiments using freshly solved AppNHp indicated a purity of ≥98%, with 1.5% AppNH2 (hydrolysis product) and no preferential binding of AppNH2 to myosin. Thus, AppNH2 does not get enriched in the active site of myosin-V as it is the case for F-actin (Cooke and Murdoch, 1973). To increase the binding affinity of AppNHp-bound myosin to F-actin (Konrad and Goody, 2005), the concentration of potassium chloride in the myosin sample buffer was reduced to 10–13 mM KCl by dilution with F-actin buffer without KCl. F-actin samples were diluted using F-actin buffer supplemented with 0.02 w/v% Tween 20. After dilution to the final concentration, the PHD-stabilized F-actin samples contained 0.4–0.9% methanol.
Protein concentrations were adjusted empirically based on the overall concentration on the grid and decoration of actin filaments. The concentration of myosin required to saturate F-actin (3–4 µM) strongly depended on the nucleotide state; while 3–4 µM myosin were sufficient in case of the rigor and strong-ADP state, 10–13 µM myosin were required for the AppNHp sample, even though the salt concentration of the buffer was lowered to increase the binding affinity.
Grids were screened on a Talos Arctica microscope (Thermo Fisher) operated at 200 kV and equipped with a Falcon III direct detector (Thermo Fisher).
In total, six different samples were plunged, screened, and imaged; also see Table 1. On the one hand, aged PHD-stabilized F-actin was decorated with myosin-V-LC in three different nucleotide states, that is, in the absence of a nucleotide and bound to either Mg2+-ADP or Mg2+-AppNHp (aged rigor, ADP, and AppNHp). For the AppNHp-bound sample, two data sets were collected from grids that were plunged using different incubation temperatures, that is, 4°C or 25°C. On the other hand, young JASP-stabilized F-actin was imaged on its own and in complex with myosin-V-LC in the rigor state (young F-actin and rigor). The corresponding grids were prepared in one plunging session, that is, within a short time frame of 1–2 hr, using the same JASP-stabilized F-actin sample.
Cryo-EM data acquisition
Data sets were acquired on Titan Krios microscopes (FEI Thermo Fisher) operated at 300 kV and equipped with a X-FEG using EPU. Specifically, data sets of the rigor and strong-ADP state were acquired on a standard Krios (Cs 2.7 mm, pixel size 1.06 Å), while a Cs-corrected Krios (pixel size 1.10 Å) was used for the remaining data sets. Equally dosed frames were collected using a K2 Summit (super-resolution mode, Gatan) direct electron detector in combination with a GIF quantum-energy filter (Bioquantum, Gatan) set to a slit width of 20 eV. For every hole, four micrographs consisting of 40 frames were collected close to the carbon edge, resulting in a total electron dose of ~79–82 eÅ–2 within an exposure time of 15 s. The defocus was varied within a range of ~0.4–3.2 µm. Acquisition details of all six data sets (aged rigor, ADP, and AppNHp 4°C + 25°C as well as young F-actin and rigor) including pixel size, electron dose, defocus range, and the total number of images collected are summarized in Table 1. Data acquisitions were monitored and evaluated live using TranSPHIRE (Stabrin et al., 2020).
Cryo-EM data processing
Data sets were automatically preprocessed on-the-fly during the data acquisition using TranSPHIRE (Stabrin et al., 2020). Preprocessing included drift correction and dose weighting by MotionCor2 (Zheng et al., 2017), CTF estimation using GCTF (Zhang, 2016), and particle picking with crYOLO (Wagner et al., 2020; Wagner et al., 2019) (filament mode, box distance 26–27 px equivalent to one rise of ~27.5 Å, minimum number of boxes 6) for all data sets. The latest version of TranSPHIRE, which was used for the processing of the AppNHp data sets, also supported automatic, on-the-fly particle extraction (box size 320 px, filament width 200 px) as well as batch-wise 2D classification (batch size 13k, filament width 200 px, radius 150 px, 60–100 particles per class), 2D class selection, and 3D refinement using software of the SPHIRE package (Moriya et al., 2017). In particular, a GPU-accelerated version of ISAC (Stabrin et al., 2020; Yang et al., 2012) and the deep-learning 2D class selection tool Cinderella (Wagner, 2020) were used. For all other data sets, particles were extracted and 2D classified after data collection using analogous settings and helical SPHIRE 1.3 (Moriya et al., 2017; Stabrin et al., 2020). Particles that were not accounted during the initial, batch-wise 2D classification, for example, because they represent rare views, were merged and inputted to another round of 2D classification until no more stable classes were found. All micrographs were assessed manually and images sorted based on ice and protein quality, resulting in a removal of 6–36% of the data sets; see Table 1 for details. Particles contributing to classes found ‘good’ by either Cinderella or manual inspection and belonging to micrographs of good quality were written to virtual particle stacks for further processing in 3D.
As an initial 3D refinement and 3D classification revealed no differences in the overall structure of myosin in the two AppNHp data sets, plunged at 4°C and 25°C, corresponding particles were merged for further processing. The final number of particles ranged from 212,660 (young JASP-stabilized F-actin) to 2,446,218 (combined AppNHp data sets); see Table 2, Table 3, Table 4 and Table 6 for details. A concise overview of all key processing steps including the number of particles and nominal resolutions can be found in Figure 1—figure supplement 1.
All data sets were processed using the helical refinement program sp_meridien_alpha.py implemented in SPHIRE 1.3 (Moriya et al., 2017; Stabrin et al., 2020). In contrast to other helical refinement routines, SPHIRE does not refine or apply any helical symmetry, and thereby avoids possible symmetrization pitfalls. Instead, the software offers the usage of constraints tailored to helical specimen, for example, on the tilt angle and shift along the filament, to guide the refinement (also see Methods section of Pospich et al., 2021). For all 3D refinements, the tilt angle was softly restrained to the equator during exhaustive searches (--theta_min 90 --theta_max 90 --howmany 10). The shift along the filament axis was furthermore limited to plus or minus half of the rise (--helical_rise 27.5) to avoid shifts larger than one subunit. Finally, the smear (number of views considered for the reprojection of each particle) was reduced to a combined weight of 90% (--ccfpercentage 90). An initial 3D reference was created from the atomic model of a previously published actomyosin complex in the rigor state (PDB:5JLH, without tropomyosin; von der Ecken et al., 2016) and filtered to 25 Å using EMAN2 (Tang et al., 2007) and SPHIRE (Moriya et al., 2017). For the initial 3D refinement, a sampling angle of 3.7°, filament width of 120 px and a radius of 144 px (45% of the box size), but no 3D mask, was used. Based on the resulting 3D density map, a wide mask covering the central 85% of the filament was created. This map and mask were then used to run a fresh, global 3D refinement using the same settings as before. Based on the results of this refinement, particles were CTF refined within SPHIRE (Moriya et al., 2017) providing the nominal resolution according to the FSC0.143-criterion. CTF-refined particles were locally 3D refined using the final map of the previous 3D refinement filtered to 4 Å as reference. The fine angular sampling typically used in local refinements makes helical restraints superfluous as projections parameters can only locally relax anyways. For this reason, particles were locally refined using the non-helical 3D refinement program sp_meridien.py in combination with a sampling angle of 0.9°, a shift range of 2 px, and a shift step size of 0.5 px. In case of the young F-actin and young rigor data sets, the resolution could be further improved by particle polishing in Relion 3.0.4 (Scheres, 2012; Zivanov et al., 2018). For this purpose, refinement results were converted to Relion star format using sp_sphire2relion.py. Metadata of the initial motion correction step required for polishing were automatically created by TranSPHIRE and were directly provided. Polished particles were transferred back to SPHIRE and passed through another round of local 3D refinement using the same settings as before.
To focus the refinement on the central part of the filament, a wide mask containing the central three actin and central two myosin-V-LC subunits including all ligands (subvolume referred to as central 3er/2er map) was created and applied in a subsequent local 3D refinement. Post refinement of the resulting half maps using a central 3er/2er mask yielded maps with average resolutions ranging from 2.9 to 3.2 Å according to the FSC0.143-criterion; see Figure 1—figure supplement 1, Table 2, Table 3, Table 4 and Table 6 for details.
With the aim to further improve the density of myosin, the signal of all subunits but the central actomyosin subunit (subvolume referred to as central 1er map) was subtracted from the 2D particle images within SPHIRE 1.3 (Moriya et al., 2017). Particles were additionally recentered to bring the center of mass close to the center of the box. Signal-subtracted particles were subjected to another round of local 3D refinement applying a central 1er mask and filtering the centered reference map to 3.5 Å. Although post refinement of the resulting half maps using a central 1er mask did not yield density maps of higher nominal resolution, the map quality of especially myosin could be significantly improved; see Figure 1—figure supplements 1–2, Table 2, Table 3, Table 4, Table 6, and Figure 7—figure supplement 2 for details.
The anisotropic quality of the final central 1er maps suggested structural heterogeneity within myosin. For this reason, signal-subtracted particles and corresponding projection parameters were transferred to and 3D classified in Relion 3.0.4 (Scheres, 2012). As domain movement was assumed to be small and to reduce the risk of overrefinement, 3D alignment was deactivated (--skip_align) and the resolution strictly limited to 8 Å (--strict_highres_exp 8). The final central 1er map filtered to 15 Å was inputted as a reference, while a corresponding wide mask was applied and solvent flattening and CTF correction activated. The regularization parameter T and number of classes K were empirically adjusted. While a parameter of T = 40 (--tau2_fudge 40) proved well suited for all data sets, finding a suitable number of classes posed a challenge. Running multiple 3D classifications with different numbers of classes resulted in classes of various, related structural states with little overlap, that is, classes of different runs could not be matched as they did generally not superimpose. The same was true when rerunning a 3D classification job using the same settings but a different seed. These results suggest a continuous structural heterogeneity of myosin in contrast to several discrete states. While software tailored to the characterization of cryo-EM data exhibiting continuous structural states has recently been published (Zhong et al., 2021), it proved unsuitable for the processing of signal-subtracted actomyosin filaments due to the need of 3D masking. To characterize the structural heterogeneity of myosin-V by standard 3D classification in Relion 3.0.4 (Scheres, 2012) as good as possible, the number of 3D classes was optimized experimentally to yield the highest number of classes with a resolution and map quality sufficient for atomic modeling (≤3.7 Å). To do so, multiple 3D classifications with varying number of classes, for example, from 2 to 12, were performed and particles split into subsets according to the classification results. Subsets were then transferred to SPHIRE and individually subjected to a local 3D refinement from stack (no reference required, same settings as before). Eventually, each subset was post-refined and the resulting map manually assessed. In the end, the 3D classification that yielded the most maps of high quality was chosen. In this way, a total of 18 high-resolution maps (referred to as 3D class averages or 3D classes) were achieved for the four actomyosin data sets. Corresponding subsets contained 81,757 to 365,722 particles; see Table 2, Table 3, Table 4 and Table 6 for details. An overview of all refined maps, associated resolutions, and the underlying number of particles is given in Figure 1—figure supplement 1.
To ease the interpretation of maps as well as model building, all final maps, that is, central 3er/2er, central 1er, and 3D class averages, were additionally filtered to local resolution using SPHIRE 1.3 (Moriya et al., 2017) and denoized using LAFTER (Ramlaul et al., 2019).
Model building, refinement, and validation
Previous cryo-EM structures of PHD-stabilized aged F-actin (PDB: 6T20; Pospich et al., 2020) and JASP-stabilized young F-actin (PDB: 5OOD; Merino et al., 2018) were used as starting models for F-actin in the rigor actomyosin complexes (aged and young rigor). The models of PHD and JASP were replaced by single-residue initial models generated from SMILES strings by elBOW (Moriarty et al., 2009) within Phenix (Adams et al., 2011) using the --amber option. The corresponding cif constraints libraries were used for all further refinements. A rigor-like crystal structure of the myosin-V-LC complex (PDB: 1OE9; Coureux et al., 2003) was used as an initial model for myosin and the bound light chain within the aged rigor structure. Stubs were replaced by full residues, and residues that are missing in the crystal structure, but are resolved in the cryo-EM density map, were added manually in Coot (Debreczeni and Emsley, 2012; Emsley et al., 2010). For all other models, that is, of the ADP, AppNHp, and young rigor state, the final refined model of the PHD-stabilized rigor actomyosin complex was used as a starting model. Initial models of nucleotides (ADP and AppNHp) are based on previous cryo-EM and crystal structures of myosin (PDB: 6C1D; Mentes et al., 2018; and PDB: 1MMN; Gulick et al., 1997). Starting models were rigid-body fitted into the density map using UCSF Chimera (Pettersen et al., 2004) and ligands were coarsely refined in Coot (Debreczeni and Emsley, 2012; Emsley et al., 2010) prior to model building.
Atomic models of the central actomyosin subunit, consisting of one F-actin, myosin, LC, and PHD/JASP molecule (central 1er), were refined using ISOLDE (Croll, 2018) within UCSF ChimeraX (Goddard et al., 2018). For this purpose, hydrogens were added to the starting model using the addh command in UCSF Chimera (Pettersen et al., 2004) and manually adjusted when necessary. Custom residue definitions for PHD and JASP were created based on the elBOW output within the ISOLDE shell. To reliably model both high- and medium-resolution features, several maps, for example, filtered to nominal or local resolution and sharpened by different B-factors, were loaded to ISOLDE. Maps filtered by LAFTER (Ramlaul et al., 2019) were also loaded for visual guidance, but excluded from the refinement (weight set to 0, MDFF deactivated). All density maps were segmented based on the starting model using the color zone tool within UCSF Chimera (Pettersen et al., 2004) to exclude density not corresponding to the central actomyosin subunit.
Each refinement in ISOLDE was started with a 2–3 min all atom simulation to reduce the overall energy of the system. Afterward, overlapping stretches of the protein and atoms within close vicinity were successively adjusted and refined. When necessary, rotamer and secondary structure restraints were introduced. After passing through the complete protein complex once, the quality of the model was assessed using the metrics provided by ISOLDE, that is, Ramachandran plot, rotamer outlier, and clash score, and outliers were locally addressed. Residues not resolved by the electron density map, for example, due to flexibility, were not included in the respective atomic model, while incompletely resolved side chains were set to most likely rotamers.
The density corresponding to the light chain was of insufficient quality for reliable model building. Hence, the model of the light chain was kept fixed during refinements in ISOLDE. Afterward, the reference crystal structure (PDB: 1OE9; Coureux et al., 2003) was rotamer-optimized in Coot and rigid-body fitted into the density using UCSF Chimera.
Finally, atomic models were real-space refined in Phenix (Adams et al., 2011; Afonine et al., 2018) against a sharpened density map filtered to nominal resolution (FSC0.143). To only relax and validate the model but prohibit large changes, local grid search, rotamer, and Ramachandran restraints were deactivated and the starting model was used as a reference. Furthermore, NCS and secondary structure restraints were applied and cif libraries provided for PHD and JASP.
Only models of the central actomyosin subunit (central 1er) were built in ISOLDE. Atomic models of subsets, that is, 3D class averages, were built starting from the average, all-particle model, and the corresponding ISOLDE/UCSF ChimeraX session including restraints. Whereas average models of different states, that is, rigor, ADP, and AppNHp, were built within new sessions to avoid any bias. Atomic models consisting of three actin and two myosin-LC subunits (central 3er/2er) were assembled from the models of the monomeric complex (central 1er) by rigid-body fitting in UCSF Chimera. The filament interface was manually inspected in Coot and side chain orientations adjusted when necessary. Finally, the multimeric model was real-space refinement in Phenix.
After real-space refinement, the residue assignment of PHD was changed from a single non-standard residue to a hepta-peptide consisting of TRP-EEP-ALA-DTH-CYS-HYP-ALA. All atomic models were assessed and validated using model-map agreement (FSC, CC), MolProbity (Chen et al., 2010), and EMRinger (Barad et al., 2015) statistics.
In total, 27 atomic models were built based on density maps with a resolution ranging from 2.9 Å to 3.7 Å; models include 4 central 1er and 5 central 3er/2er all-particle models as well as 18 models representing subsets identified by 3D classification (see Table 2, Table 3, Table 4 and Table 6 for details).
Structural analysis and visualization
Figures and movies were created with UCSF Chimera (Pettersen et al., 2004) and modified using image or movie processing software when required.
For the visualization of myosin and the actomyosin interface, central 1er (central actomyosin subunit) and central 3er/2er (central three F-actin and two myosin molecules) models and maps are shown, respectively, as they include all important contact sites and are best resolved. Models protonated by H++ (Anandakrishnan et al., 2012) at pH 7.5 with HIC replaced by HIS were used for all surface representations. To optimally visualize features of different local resolution, a variety of maps are displayed within figures and movies (also see legends). Specifically, LAFTER maps are used to visualize the complete actomyosin structure and features of lower resolution, while post-refined maps are shown in close-up views, for example, of the active site.
Relative rotation angles of the lever arm were computed as angles between axes created for the corresponding helices in Chimera (Pettersen et al., 2004) using default settings.
Protein-protein and protein-ligand interactions were analyzed with PDBsum (Laskowski, 2009). Conformational changes and structural heterogeneity of the central 1er models were characterized by PCA using the Bio3d library (Grant et al., 2006) in R (R Core Team, 2017). Initially, model sequences were aligned using the pdbaln method. With the help of the methods core.find and pdbfit, models were then superimposed on an automatically determined structural stable core, which encompasses almost the complete F-actin subunit and parts of the HLH-motif in the L50 domain. PCA was performed running px.xray, excluding gaps within the sequence and ligands. Data points were manually grouped and colored based on the underlying data set and type of model, that is, average model vs. 3D class average. For the direct visualization of PCA results, trajectories along each principal component were exported using mktrj.pca and morphed in UCSF Chimera (Pettersen et al., 2004). Mobile domains within myosin (central 1er, chain A) and their motion were identified and analyzed using DynDom (Hayward and Lee, 2002).
Data availability
The atomic models and cryo-EM maps are available in the PDB (Burley et al., 2019) and EMDB databases (Lawson et al., 2011) under the following accession numbers: aged PHD-stabilized actomyosin-V in the strong-ADP state: 7PM5, EMD-13521 (central 1er), 7PM6, EMD-13522 (central 3er/2er), 7PM7, EMD-13523 (class 2), 7PM8, EMD-13524 (class 3), 7PM9, EMD-13525 (class 4), 7PMA, EMD-13526 (class 5), 7PMB, EMD-13527 (class 6), 7PMC, EMD-13528 (class 7); aged PHD-stabilized actomyosin-V in the rigor state: 7PLT, EMD-13501 (central 1er), 7PLU, EMD-13502 (central 3er/2er), 7PLV, EMD-13503 (class 1), 7PLW, EMD-13504 (class 3) and 7PLX, EMD-13505 (class 4); aged PHD-stabilized actomyosin-V in the PRT state: 7PMD, EMD-13529 (central 1er), 7PME, EMD-13530 (central 3er/2er), 7PMF, EMD-13531 (class 1), 7PMG, EMD-13532 (class 3), 7PMH, EMD-13533 (class 4), 7PMI, EMD-13535 (class 5), 7PMJ, EMD-13536 (class 6), 7PML, EMD-13538 (class 8); young JASP-stabilized actomyosin-V in the rigor state: 7PLY, EMD-13506 (central 1er), 7PLZ, EMD-13507 (central 3er/2er), 7PM0, EMD-13508 (class 1), 7PM1, EMD-13509 (class 2), 7PM2, EMD-13510 (class 4); and young JASP-stabilized F-actin: 7PM3, EMD-13511. The data sets generated during the current study are available from the corresponding author upon reasonable request.
Acknowledgements
We thank E Sirikia for the purification of myosin-V from SF9 cells. We thank O Hofnagel and D Prumbaum for assistance with data collection. We thank W Linke and A Unger for providing us with muscle acetone powder. We thank RS Goody for his friendly advice. This work was supported by the Max Planck Society (to SR), the European Research Council under the European Union’s Horizon 2020 Programme (ERC-2019-SyG, grant 856118) (to SR), the Centre national de la recherche scientifique (to AH), the Agence nationale de la recherche (grant ANR-17-CE11-0029-01) (to AH), and the National Institutes of Health (grant R01-DC009100) (to HLS). SP was supported as a fellow of Studienstiftung des deutschen Volkes.
Funding Statement
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Contributor Information
Stefan Raunser, Email: stefan.raunser@mpi-dortmund.mpg.de.
Samara L Reck-Peterson, University of California, San Diego, United States.
José D Faraldo-Gómez, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, United States.
Funding Information
This paper was supported by the following grants:
Max-Planck-Gesellschaft to Stefan Raunser.
Horizon 2020 ERC-2019-SyG 856118 to Stefan Raunser.
Agence Nationale de la Recherche ANR-17-CE11-0029-01 to Anne Houdusse.
National Institutes of Health R01-DC009100 to H Lee Sweeney.
Centre National de la Recherche Scientifique to Anne Houdusse.
Studienstiftung des Deutschen Volkes to Sabrina Pospich.
Additional information
Competing interests
No competing interests declared.
Author contributions
Data curation, Formal analysis, Investigation, Methodology, Validation, Visualization, Writing - original draft, Writing - review and editing.
Conceptualization, Writing - review and editing.
Conceptualization, Writing - review and editing.
Conceptualization, Funding acquisition, Project administration, Supervision, Writing - review and editing.
Additional files
Data availability
The atomic models and cryo-EM maps are available in the PDB (Burley et al., 2018) and EMDB databases (Lawson et al., 2011), under following accession numbers: aged PHD-stabilized actomyosin-V in the strong-ADP state: 7PM5, EMD-13521 (central 1er), 7PM6, EMD-13522 (central 3er/2er), 7PM7, EMD-13523 (class 2), 7PM8, EMD-13524 (class 3), 7PM9, EMD-13525 (class 4), 7PMA, EMD-13526 (class 5), 7PMB, EMD-13527 (class 6), 7PMC, EMD-13528 (class 7) ; aged PHD-stabilized actomyosin-V in the rigor state: 7PLT, EMD-13501 (central 1er), 7PLU, EMD-13502 (central 3er/2er), 7PLV, EMD-13503 (class 1), 7PLW, EMD-13504 (class 3) and 7PLX, EMD-13505 (class 4); aged PHD-stabilized actomyosin-V in the PRT state: 7PMD, EMD-13529 (central 1er), 7PME, EMD-13530 (central 3er/2er), 7PMF, EMD-13531 (class 1), 7PMG, EMD-13532 (class 3), 7PMH, EMD-13533 (class 4), 7PMI, EMD-13535 (class 5), 7PMJ, EMD-13536 (class 6), 7PML, EMD-13538 (class 8); young JASP-stabilized actomyosin-V in the rigor state: 7PLY, EMD-13506 (central 1er), 7PLZ, EMD-13507 (central 3er/2er), 7PM0, EMD-13508 (class 1), 7PM1, EMD-13509 (class 2), 7PM2, EMD-13510 (class 4); and young JASP-stabilized F-actin: 7PM3, EMD-13511.
The following datasets were generated:
Pospich S, Sweeney H L, Houdusse A, Raunser S. 2021. Cryo-EM structure of the actomyosin-V complex in the strong-ADP state (central 1er) RCSB Protein Data Bank. 7PM5
Pospich S, Sweeney H L, Houdusse A, Raunser S. 2021. Cryo-EM structure of the actomyosin-V complex in the strong-ADP state (central 3er/2er) RCSB Protein Data Bank. 7PM6
Pospich S, Sweeney H L, Houdusse A, Raunser S. 2021. Cryo-EM structure of the actomyosin-V complex in the strong-ADP state (central 1er, class 2) RCSB Protein Data Bank. 7PM7
Pospich S, Sweeney H L, Houdusse A, Raunser S. 2021. Cryo-EM structure of the actomyosin-V complex in the strong-ADP state (central 1er, class 3) RCSB Protein Data Bank. 7PM8
Pospich S, Sweeney H L, Houdusse A, Raunser S. 2021. Cryo-EM structure of the actomyosin-V complex in the strong-ADP state (central 1er, class 4) RCSB Protein Data Bank. 7PM9
Pospich S, Sweeney H L, Houdusse A, Raunser S. 2021. Cryo-EM structure of the actomyosin-V complex in the strong-ADP state (central 1er, class 5) RCSB Protein Data Bank. 7PMA
Pospich S, Sweeney H L, Houdusse A, Raunser S. 2021. Cryo-EM structure of the actomyosin-V complex in the strong-ADP state (central 1er, class 6) RCSB Protein Data Bank. 7PMB
Pospich S, Sweeney H L, Houdusse A, Raunser S. 2021. Cryo-EM structure of the actomyosin-V complex in the strong-ADP state (central 1er, class 7) RCSB Protein Data Bank. 7PMC
Pospich S, Sweeney H L, Houdusse A, Raunser S. 2021. Cryo-EM structure of the actomyosin-V complex in the rigor state (central 1er) RCSB Protein Data Bank. 7PLT
Pospich S, Sweeney H L, Houdusse A, Raunser S. 2021. Cryo-EM structure of the actomyosin-V complex in the rigor state (central 3er/2er) RCSB Protein Data Bank. 7PLU
Pospich S, Sweeney H L, Houdusse A, Raunser S. 2021. Cryo-EM structure of the actomyosin-V complex in the rigor state (central 1er, class 1) RCSB Protein Data Bank. 7PLV
Pospich S, Sweeney H L, Houdusse A, Raunser S. 2021. Cryo-EM structure of the actomyosin-V complex in the rigor state (central 1er, class 2) RCSB Protein Data Bank. 7PLW
Pospich S, Sweeney H L, Houdusse A, Raunser S. 2021. Cryo-EM structure of the actomyosin-V complex in the rigor state (central 1er, class 4) RCSB Protein Data Bank. 7PLX
Pospich S, Sweeney H L, Houdusse A, Raunser S. 2021. Cryo-EM structure of the actomyosin-V complex in the post-rigor transition state (AppNHp, central 1er) RCSB Protein Data Bank. 7PMD
Pospich S, Sweeney H L, Houdusse A, Raunser S. 2021. Cryo-EM structure of the actomyosin-V complex in the post-rigor transition state (AppNHp, central 3er/2er) RCSB Protein Data Bank. 7PME
Pospich S, Sweeney H L, Houdusse A, Raunser S. 2021. Cryo-EM structure of the actomyosin-V complex in the post-rigor transition state (AppNHp, central 1er, class 1) RCSB Protein Data Bank. 7PMF
Pospich S, Sweeney H L, Houdusse A, Raunser S. 2021. Cryo-EM structure of the actomyosin-V complex in the post-rigor transition state (AppNHp, central 1er, class 3) RCSB Protein Data Bank. 7PMG
Pospich S, Sweeney H L, Houdusse A, Raunser S. 2021. Cryo-EM structure of the actomyosin-V complex in the post-rigor transition state (AppNHp, central 1er, class 4) RCSB Protein Data Bank. 7PMH
Pospich S, Sweeney H L, Houdusse A, Raunser S. 2021. Cryo-EM structure of the actomyosin-V complex in the post-rigor transition state (AppNHp, central 1er, class 5) RCSB Protein Data Bank. 7PMI
Pospich S, Sweeney H L, Houdusse A, Raunser S. 2021. Cryo-EM structure of the actomyosin-V complex in the post-rigor transition state (AppNHp, central 1er, class 6) RCSB Protein Data Bank. 7PMJ
Pospich S, Sweeney H L, Houdusse A, Raunser S. 2021. Cryo-EM structure of the actomyosin-V complex in the post-rigor transition state (AppNHp, central 1er, class 8) RCSB Protein Data Bank. 7PML
Pospich S, Sweeney H L, Houdusse A, Raunser S. 2021. Cryo-EM structure of the actomyosin-V complex in the rigor state (central 1er, young JASP-stabilized F-actin) RCSB Protein Data Bank. 7PLY
Pospich S, Sweeney H L, Houdusse A, Raunser S. 2021. Cryo-EM structure of the actomyosin-V complex in the rigor state (central 3er/2er, young JASP-stabilized F-actin) RCSB Protein Data Bank. 7PLZ
Pospich S, Sweeney H L, Houdusse A, Raunser S. 2021. Cryo-EM structure of the actomyosin-V complex in the rigor state (central 1er, young JASP-stabilized F-actin, class 1) RCSB Protein Data Bank. 7PM0
Pospich S, Sweeney H L, Houdusse A, Raunser S. 2021. Cryo-EM structure of the actomyosin-V complex in the rigor state (central 1er, young JASP-stabilized F-actin, class 2) RCSB Protein Data Bank. 7PM1
Pospich S, Sweeney H L, Houdusse A, Raunser S. 2021. Cryo-EM structure of the actomyosin-V complex in the rigor state (central 1er, young JASP-stabilized F-actin, class 4) RCSB Protein Data Bank. 7PM2
Pospich S, Sweeney H L, Houdusse A, Raunser S. 2021. Cryo-EM structure of young JASP-stabilized F-actin (central 3er) RCSB Protein Data Bank. 7PM3
References
- Adams PD, Afonine PV, Bunkóczi G, Chen VB, Echols N, Headd JJ, Hung L-W, Jain S, Kapral GJ, Grosse Kunstleve RW, McCoy AJ, Moriarty NW, Oeffner RD, Read RJ, Richardson DC, Richardson JS, Terwilliger TC, Zwart PH. The Phenix software for automated determination of macromolecular structures. Methods. 2011;55:94–106. doi: 10.1016/j.ymeth.2011.07.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Afonine PV, Poon BK, Read RJ, Sobolev OV, Terwilliger TC, Urzhumtsev A, Adams PD. Real-space refinement in PHENIX for cryo-EM and crystallography. Acta Crystallographica. Section D, Structural Biology. 2018;74:531–544. doi: 10.1107/S2059798318006551. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Anandakrishnan R, Aguilar B, Onufriev AV. H++ 3.0: automating pK prediction and the preparation of biomolecular structures for atomistic molecular modeling and simulations. Nucleic Acids Research. 2012;40:W537–W541. doi: 10.1093/nar/gks375. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Anson M, Drummond DR, Geeves MA, Hennessey ES, Ritchie MD, Sparrow JC. Actomyosin kinetics and in vitro motility of wild-type Drosophila actin and the effects of two mutations in the Act88F gene. Biophysical Journal. 1995;68:1991–2003. doi: 10.1016/S0006-3495(95)80376-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Banerjee C, Hu Z, Huang Z, Warrington JA, Taylor DW, Trybus KM, Lowey S, Taylor KA. The structure of the actin-smooth muscle myosin motor domain complex in the rigor state. Journal of Structural Biology. 2017;200:325–333. doi: 10.1016/j.jsb.2017.10.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Barad BA, Echols N, Wang RYR, Cheng Y, DiMaio F, Adams PD, Fraser JS. EMRinger: side chain-directed model and map validation for 3D cryo-electron microscopy. Nature Methods. 2015;12:943–946. doi: 10.1038/nmeth.3541. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bauer CB, Holden HM, Thoden JB, Smith R, Rayment I. X-ray structures of the apo and MgATP-bound states of Dictyostelium discoideum myosin motor domain. The Journal of Biological Chemistry. 2000;275:38494–38499. doi: 10.1074/jbc.M005585200. [DOI] [PubMed] [Google Scholar]
- Behrmann E, Müller M, Penczek PA, Mannherz HG, Manstein DJ, Raunser S. Structure of the rigor actin-tropomyosin-myosin complex. Cell. 2012;150:327–338. doi: 10.1016/j.cell.2012.05.037. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Blanc F, Isabet T, Benisty H, Sweeney HL, Cecchini M, Houdusse A. An intermediate along the recovery stroke of myosin VI revealed by X-ray crystallography and molecular dynamics. PNAS. 2018;115:6213–6218. doi: 10.1073/pnas.1711512115. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bloemink MJ, Hsu KH, Geeves MA, Bernstein SI. Alternative N-terminal regions of Drosophila myosin heavy chain II regulate communication of the purine binding loop with the essential light chain. The Journal of Biological Chemistry. 2020;295:14522–14535. doi: 10.1074/jbc.RA120.014684. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Burley SK, Berman HM, Bhikadiya C, Bi C, Chen L, Di Costanzo L, Christie C, Dalenberg K, Duarte JM, Dutta S, Feng Z, Ghosh S, Goodsell DS, Green RK, Guranović V, Guzenko D, Hudson BP, Kalro T, Liang Y, Lowe R, Namkoong H, Peisach E, Periskova I, Prlić A, Randle C, Rose A, Rose P, Sala R, Sekharan M, Shao C, Tan L, Tao Y-P, Valasatava Y, Voigt M, Westbrook J, Woo J, Yang H, Young J, Zhuravleva M, Zardecki C. RCSB Protein Data Bank: biological macromolecular structures enabling research and education in fundamental biology, biomedicine, biotechnology and energy. Nucleic Acids Research. 2019;47:D464–D474. doi: 10.1093/nar/gky1004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cai L, Makhov AM, Bear JE. F-actin binding is essential for coronin 1B function in vivo. Journal of Cell Science. 2007;120:1779–1790. doi: 10.1242/jcs.007641. [DOI] [PubMed] [Google Scholar]
- Chen VB, Arendall WB, Headd JJ, Keedy DA, Immormino RM, Kapral GJ, Murray LW, Richardson JS, Richardson DC. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallographica. Section D, Biological Crystallography. 2010;66:12–21. doi: 10.1107/S0907444909042073. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chou SZ, Pollard TD. Cryo-electron microscopy structures of pyrene-labeled ADP-Pi- and ADP-actin filaments. Nature Communications. 2020;11:5897–5899. doi: 10.1038/s41467-020-19762-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Coluccio LM. Myosins. Medicine & Biology. 2020;1239:439–451. doi: 10.1007/978-3-030-38062-5_20. [DOI] [PubMed] [Google Scholar]
- Cooke R, Murdoch L. Interaction of actin with analogs of adenosine triphosphate. Biochemistry. 1973;12:3927–3932. doi: 10.1021/bi00744a022. [DOI] [PubMed] [Google Scholar]
- Cope MJ, Whisstock J, Rayment I, Kendrick-Jones J. Conservation within the myosin motor domain: implications for structure and function. Structure. 1996;4:969–987. doi: 10.1016/s0969-2126(96)00103-7. [DOI] [PubMed] [Google Scholar]
- Coureux PD, Wells AL, Ménétrey J, Yengo CM, Morris CA, Sweeney HL, Houdusse A. A structural state of the myosin V motor without bound nucleotide. Nature. 2003;425:419–423. doi: 10.1038/nature01927. [DOI] [PubMed] [Google Scholar]
- Coureux PD, Sweeney HL, Houdusse A. Three myosin V structures delineate essential features of chemo-mechanical transduction. The EMBO Journal. 2004;23:4527–4537. doi: 10.1038/sj.emboj.7600458. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Crews P, Manes LV, Boehler M. Jasplakinolide, a cyclodepsipeptide from the marine sponge, SP. Tetrahedron Letters. 1986;27:2797–2800. doi: 10.1016/S0040-4039(00)84645-6. [DOI] [Google Scholar]
- Croll TI. ISOLDE: a physically realistic environment for model building into low-resolution electron-density maps. Acta Crystallographica. Section D, Structural Biology. 2018;74:519–530. doi: 10.1107/S2059798318002425. [DOI] [PMC free article] [PubMed] [Google Scholar]
- De La Cruz EM, Wells AL, Rosenfeld SS, Ostap EM, Sweeney HL. The kinetic mechanism of myosin V. PNAS. 1999;96:13726–13731. doi: 10.1073/pnas.96.24.13726. [DOI] [PMC free article] [PubMed] [Google Scholar]
- De La Cruz EM, Wells AL, Sweeney HL, Ostap EM. Actin and light chain isoform dependence of myosin V kinetics. Biochemistry. 2000;39:14196–14202. doi: 10.1021/bi001701b. [DOI] [PubMed] [Google Scholar]
- De La Cruz EM, Ostap EM, Sweeney HL. Kinetic mechanism and regulation of myosin VI. The Journal of Biological Chemistry. 2001;276:32373–32381. doi: 10.1074/jbc.M104136200. [DOI] [PubMed] [Google Scholar]
- De La Cruz EM, Ostap EM. Relating biochemistry and function in the myosin superfamily. Current Opinion in Cell Biology. 2004;16:61–67. doi: 10.1016/j.ceb.2003.11.011. [DOI] [PubMed] [Google Scholar]
- Debreczeni JÉ, Emsley P. Handling ligands with Coot. Acta Crystallographica. Section D, Biological Crystallography. 2012;68:425–430. doi: 10.1107/S0907444912000200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Doran MH, Pavadai E, Rynkiewicz MJ, Walklate J, Bullitt E, Moore JR, Regnier M, Geeves MA, Lehman W. Cryo-EM and Molecular Docking Shows Myosin Loop 4 Contacts Actin and Tropomyosin on Thin Filaments. Biophysical Journal. 2020;119:821–830. doi: 10.1016/j.bpj.2020.07.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Drummond DR, Peckham M, Sparrow JC, White DC. Alteration in crossbridge kinetics caused by mutations in actin. Nature. 1990;348:440–442. doi: 10.1038/348440a0. [DOI] [PubMed] [Google Scholar]
- Emsley P, Lohkamp B, Scott WG, Cowtan K. Features and development of Coot. Acta Crystallographica. Section D, Biological Crystallography. 2010;66:486–501. doi: 10.1107/S0907444910007493. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fischer S, Windshügel B, Horak D, Holmes KC, Smith JC. Structural mechanism of the recovery stroke in the myosin molecular motor. PNAS. 2005;102:6873–6878. doi: 10.1073/pnas.0408784102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Forkey JN, Quinlan ME, Shaw MA, Corrie JET, Goldman YE. Three-dimensional structural dynamics of myosin V by single-molecule fluorescence polarization. Nature. 2003;422:399–404. doi: 10.1038/nature01529. [DOI] [PubMed] [Google Scholar]
- Fujii T, Namba K. Structure of actomyosin rigour complex at 5.2 Å resolution and insights into the ATPase cycle mechanism. Nature Communications. 2017;8:13969. doi: 10.1038/ncomms13969. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Geeves MA, Fedorov R, Manstein DJ. Molecular mechanism of actomyosin-based motility. Cellular and Molecular Life Sciences. 2005;62:1462–1477. doi: 10.1007/s00018-005-5015-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Goddard TD, Huang CC, Meng EC, Pettersen EF, Couch GS, Morris JH, Ferrin TE. UCSF ChimeraX: Meeting modern challenges in visualization and analysis. Protein Science. 2018;27:14–25. doi: 10.1002/pro.3235. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gong R, Jiang F, Moreland ZG, Reynolds MJ, de los Reyes SE, Gurel PS, Shams A. Structural Basis for Tunable Control of Actin Dynamics by Myosin-15 in Mechanosensory Stereocilia. bioRxiv. 2021 doi: 10.1101/2021.07.09.451843. [DOI] [PMC free article] [PubMed]
- Grant BJ, Rodrigues APC, ElSawy KM, McCammon JA, Caves LSD. Bio3d: an R package for the comparative analysis of protein structures. Bioinformatics. 2006;22:2695–2696. doi: 10.1093/bioinformatics/btl461. [DOI] [PubMed] [Google Scholar]
- Gulick AM, Bauer CB, Thoden JB, Rayment I. X-ray structures of the MgADP, MgATPgammaS, and MgAMPPNP complexes of the Dictyostelium discoideum myosin motor domain. Biochemistry. 1997;36:11619–11628. doi: 10.1021/bi9712596. [DOI] [PubMed] [Google Scholar]
- Gurel PS, Kim LY, Ruijgrok PV, Omabegho T, Bryant Z, Alushin GM. Cryo-EM structures reveal specialization at the myosin VI-actin interface and a mechanism of force sensitivity. eLife. 2017;6:e31125. doi: 10.7554/eLife.31125. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hanson J, Huxley HE. Structural basis of the cross-striations in muscle. Nature. 1953;172:530–532. doi: 10.1038/172530b0. [DOI] [PubMed] [Google Scholar]
- Hartman MA, Finan D, Sivaramakrishnan S, Spudich JA. Principles of unconventional myosin function and targeting. Annual Review of Cell and Developmental Biology. 2011;27:133–155. doi: 10.1146/annurev-cellbio-100809-151502. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hayward S, Lee RA. Improvements in the analysis of domain motions in proteins from conformational change: DynDom version 1.50. Journal of Molecular Graphics and Modelling. 2002;21:181–183. doi: 10.1016/S1093-3263(02)00140-7. [DOI] [PubMed] [Google Scholar]
- Hertzog M, Carlier MF. Functional characterization of proteins regulating actin assembly; Current protocols in cell biology. Chapter. 2005;13:S26. doi: 10.1002/0471143030.cb1306s26. [DOI] [PubMed] [Google Scholar]
- Holmes KC. The swinging lever-arm hypothesis of muscle contraction. Current Biology. 1997;7:R112–R118. doi: 10.1016/s0960-9822(06)00051-0. [DOI] [PubMed] [Google Scholar]
- Hopp TP, Prickett KS, Price VL, Libby RT, March CJ, Pat Cerretti D, Urdal DL, Conlon PJ. A Short Polypeptide Marker Sequence Useful for Recombinant Protein Identification and Purification. Bio/Technology. 1988;6:1204–1210. doi: 10.1038/nbt1088-1204. [DOI] [Google Scholar]
- Huxley HE. The Contraction of Muscle. Scientific American. 1958;199:66–83. doi: 10.1038/scientificamerican1158-66. [DOI] [PubMed] [Google Scholar]
- Kim E, Bobkova E, Hegyi G, Muhlrad A, Reisler E. Actin cross-linking and inhibition of the actomyosin motor. Biochemistry. 2002;41:86–93. doi: 10.1021/bi0113824. [DOI] [PubMed] [Google Scholar]
- Klein JC, Burr AR, Svensson B, Kennedy DJ, Allingham J, Titus MA, Rayment I, Thomas DD. Actin-binding cleft closure in myosin II probed by site-directed spin labeling and pulsed EPR. PNAS. 2008;105:12867–12872. doi: 10.1073/pnas.0802286105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kollmar M, Dürrwang U, Kliche W, Manstein DJ, Kull FJ. Crystal structure of the motor domain of a class-I myosin. The EMBO Journal. 2002;21:2517–2525. doi: 10.1093/emboj/21.11.2517. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Konrad M, Goody RS. Kinetic and Thermodynamic Properties of the Ternary Complex between F-actin, Myosin Subfragment 1 and Adenosine 5′-[β,γ-imido]triphosphate. European Journal of Biochemistry. 2005;128:547–555. doi: 10.1111/j.1432-1033.1982.tb07000.x. [DOI] [PubMed] [Google Scholar]
- Korman VL, Anderson SEB, Prochniewicz E, Titus MA, Thomas DD. Structural dynamics of the actin-myosin interface by site-directed spectroscopy. Journal of Molecular Biology. 2006;356:1107–1117. doi: 10.1016/j.jmb.2005.10.024. [DOI] [PubMed] [Google Scholar]
- Kouyama T, Mihashi K. Fluorimetry study of N-(1-pyrenyl)iodoacetamide-labelled F-actin: Local structural change of actin protomer both on polymerization and on binding of heavy meromyosin. European Journal of Biochemistry / FEBS. 1981;114:33–38. doi: 10.1111/j.1432-1033.1981.tb06167.x. [DOI] [PubMed] [Google Scholar]
- Kovács M, Thirumurugan K, Knight PJ, Sellers JR. Load-dependent mechanism of nonmuscle myosin 2. PNAS. 2007;104:9994–9999. doi: 10.1073/pnas.0701181104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Krendel M, Mooseker MS. Myosins: tails (and heads) of functional diversity. Physiology. 2005;20:239–251. doi: 10.1152/physiol.00014.2005. [DOI] [PubMed] [Google Scholar]
- Kueh HY, Mitchison TJ. Structural plasticity in actin and tubulin polymer dynamics. Science. 2009;325:960–963. doi: 10.1126/science.1168823. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kühner S, Fischer S. Structural mechanism of the ATP-induced dissociation of rigor myosin from actin. PNAS. 2011;108:7793–7798. doi: 10.1073/pnas.1018420108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kull FJ, Endow SA. Force generation by kinesin and myosin cytoskeletal motor proteins. Journal of Cell Science. 2013;126:9–19. doi: 10.1242/jcs.103911. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Laakso JM, Lewis JH, Shuman H, Ostap EM. Myosin I can act as a molecular force sensor. Science. 2008;321:133–136. doi: 10.1126/science.1159419. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Laskowski RA. PDBsum new things. Nucleic Acids Research. 2009;37:D355–D359. doi: 10.1093/nar/gkn860. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Laskowski RA, Jabłońska J, Pravda L, Vařeková RS, Thornton JM. PDBsum: Structural summaries of PDB entries. Protein Science. 2018;27:129–134. doi: 10.1002/pro.3289. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lawson CL, Baker ML, Best C, Bi C, Dougherty M, Feng P, van Ginkel G, Devkota B, Lagerstedt I, Ludtke SJ, Newman RH, Oldfield TJ, Rees I, Sahni G, Sala R, Velankar S, Warren J, Westbrook JD, Henrick K, Kleywegt GJ, Berman HM, Chiu W. EMDataBank.org: unified data resource for CryoEM. Nucleic Acids Research. 2011;39:D456–D464. doi: 10.1093/nar/gkq880. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lehman W, Orzechowski M, Li XE, Fischer S, Raunser S. Gestalt-binding of tropomyosin on actin during thin filament activation. Journal of Muscle Research and Cell Motility. 2013;34:155–163. doi: 10.1007/s10974-013-9342-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lewis JH, Lin T, Hokanson DE, Ostap EM. Temperature dependence of nucleotide association and kinetic characterization of myo1b. Biochemistry. 2006;45:11589–11597. doi: 10.1021/bi0611917. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Llinas P, Isabet T, Song L, Ropars V, Zong B, Benisty H, Sirigu S, Morris C, Kikuti C, Safer D, Sweeney HL, Houdusse A. How actin initiates the motor activity of Myosin. Developmental Cell. 2015;33:401–412. doi: 10.1016/j.devcel.2015.03.025. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lymn RW, Taylor EW. Mechanism of adenosine triphosphate hydrolysis by actomyosin. Biochemistry. 1971;10:4617–4624. doi: 10.1021/bi00801a004. [DOI] [PubMed] [Google Scholar]
- Lynen F, Wieland U. Über die Giftstoffe des Knollenblätterpilzes IV. Justus Liebig’s Annalen Der Chemie. 1938;533:93–117. doi: 10.1002/jlac.19385330105. [DOI] [Google Scholar]
- Mentes A, Huehn A, Liu X, Zwolak A, Dominguez R, Shuman H, Ostap EM. High-resolution cryo-EM structures of actin-bound myosin states reveal the mechanism of myosin force sensing. PNAS. 2018;110:201718316. doi: 10.1073/pnas.1718316115. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Merino F, Pospich S, Funk J, Wagner T, Küllmer F, Arndt H-D, Bieling P, Raunser S. Structural transitions of F-actin upon ATP hydrolysis at near-atomic resolution revealed by cryo-EM. Nature Structural & Molecular Biology. 2018;25:528–537. doi: 10.1038/s41594-018-0074-0. [DOI] [PubMed] [Google Scholar]
- Merino F, Pospich S, Raunser S. Towards a structural understanding of the remodeling of the actin cytoskeleton. Seminars in Cell & Developmental Biology. 2020;102:51–64. doi: 10.1016/j.semcdb.2019.11.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Milligan RA, Whittaker M, Safer D. Molecular structure of F-actin and location of surface binding sites. Nature. 1990;348:217–221. doi: 10.1038/348217a0. [DOI] [PubMed] [Google Scholar]
- Moriarty NW, Grosse-Kunstleve RW, Adams PD. electronic Ligand Builder and Optimization Workbench (eLBOW): a tool for ligand coordinate and restraint generation. Acta Crystallographica. Section D, Biological Crystallography. 2009;65:1074–1080. doi: 10.1107/S0907444909029436. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Moriya T, Saur M, Stabrin M, Merino F, Voicu H, Huang Z, Penczek PA, Raunser S, Gatsogiannis C. High-resolution Single Particle Analysis from Electron Cryo-microscopy Images Using SPHIRE. Journal of Visualized Experiments. 2017;123:e55448. doi: 10.3791/55448. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Naber N, Málnási-Csizmadia A, Purcell TJ, Cooke R, Pate E. Combining EPR with fluorescence spectroscopy to monitor conformational changes at the myosin nucleotide pocket. Journal of Molecular Biology. 2010;396:937–948. doi: 10.1016/j.jmb.2009.12.035. [DOI] [PubMed] [Google Scholar]
- Nesmelov YE, Agafonov RV, Burr AR, Weber RT, Thomas DD. Structure and dynamics of the force-generating domain of myosin probed by multifrequency electron paramagnetic resonance. Biophysical Journal. 2008;95:247–256. doi: 10.1529/biophysj.107.124305. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nesmelov YE, Agafonov RV, Negrashov IV, Blakely SE, Titus MA, Thomas DD. Structural kinetics of myosin by transient time-resolved FRET. PNAS. 2011;108:1891–1896. doi: 10.1073/pnas.1012320108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nishikawa S, Homma K, Komori Y, Iwaki M, Wazawa T, Hikikoshi Iwane A, Saito J, Ikebe R, Katayama E, Yanagida T, Ikebe M. Class VI myosin moves processively along actin filaments backward with large steps. Biochemical and Biophysical Research Communications. 2002;290:311–317. doi: 10.1006/bbrc.2001.6142. [DOI] [PubMed] [Google Scholar]
- Noguchi TQP, Komori T, Umeki N, Demizu N, Ito K, Iwane AH, Tokuraku K, Yanagida T, Uyeda TQP. G146V mutation at the hinge region of actin reveals a myosin class-specific requirement of actin conformations for motility. The Journal of Biological Chemistry. 2012;287:24339–24345. doi: 10.1074/jbc.M111.321752. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Oztug Durer ZA, Kamal JKA, Benchaar S, Chance MR, Reisler E. Myosin binding surface on actin probed by hydroxyl radical footprinting and site-directed labels. Journal of Molecular Biology. 2011;414:204–216. doi: 10.1016/j.jmb.2011.09.035. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pardee JD, Spudich JA. Purification of muscle actin. Cell Biology. 1982;24:271–281. doi: 10.1016/s0091-679x(08)60661-5. [DOI] [PubMed] [Google Scholar]
- Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE. UCSF Chimera--a visualization system for exploratory research and analysis. Journal of Computational Chemistry. 2004;25:1605–1612. doi: 10.1002/jcc.20084. [DOI] [PubMed] [Google Scholar]
- Pospich S, Kumpula EP, von der Ecken J, Vahokoski J, Kursula I, Raunser S. Near-atomic structure of jasplakinolide-stabilized malaria parasite F-actin reveals the structural basis of filament instability. PNAS. 2017;114:10636–10641. doi: 10.1073/pnas.1707506114. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pospich S, Raunser S. Single particle cryo-EM-an optimal tool to study cytoskeletal proteins. Current Opinion in Structural Biology. 2018;52:16–24. doi: 10.1016/j.sbi.2018.07.006. [DOI] [PubMed] [Google Scholar]
- Pospich S, Merino F, Raunser S. Structural Effects and Functional Implications of Phalloidin and Jasplakinolide Binding to Actin Filaments. Structure. 2020;28:437–449. doi: 10.1016/j.str.2020.01.014. [DOI] [PubMed] [Google Scholar]
- Pospich S, Küllmer F, Nasufović V, Funk J, Belyy A, Bieling P, Arndt H, Raunser S. Cryo‐EM Resolves Molecular Recognition Of An Optojasp Photoswitch Bound To Actin Filaments In Both Switch States. Angewandte Chemie International Edition. 2021;60:8678–8682. doi: 10.1002/anie.202013193. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Prochniewicz E, Thomas DD. Site-specific mutations in the myosin binding sites of actin affect structural transitions that control myosin binding. Biochemistry. 2001;40:13933–13940. doi: 10.1021/bi010893n. [DOI] [PubMed] [Google Scholar]
- Prochniewicz E, Chin HF, Henn A, Hannemann DE, Olivares AO, Thomas DD, De La Cruz EM. Myosin isoform determines the conformational dynamics and cooperativity of actin filaments in the strongly bound actomyosin complex. Journal of Molecular Biology. 2010;396:501–509. doi: 10.1016/j.jmb.2009.11.063. [DOI] [PMC free article] [PubMed] [Google Scholar]
- R Core Team R: A language and environment for statistical computing. Retrieved from. 2017. [October 31, 2017]. https://www.R-project.org/
- Ramlaul K, Palmer CM, Aylett CHS. A Local Agreement Filtering Algorithm for Transmission EM Reconstructions. Journal of Structural Biology. 2019;205:30–40. doi: 10.1016/j.jsb.2018.11.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rayment I, Holden HM, Whittaker M, Yohn CB, Lorenz M, Holmes KC, Milligan RA. Structure of the actin-myosin complex and its implications for muscle contraction. Science. 1993a;261:58–65. doi: 10.1126/science.8316858. [DOI] [PubMed] [Google Scholar]
- Rayment I, Rypniewski W, Schmidt-Base K, Smith R, Tomchick D, Benning M, Winkelmann D, Wesenberg G, Holden H. Three-dimensional structure of myosin subfragment-1: a molecular motor. Science. 1993b;261:50–58. doi: 10.1126/science.8316857. [DOI] [PubMed] [Google Scholar]
- Risi C, Eisner J, Belknap B, Heeley DH, White HD, Schröder GF, Galkin VE. Ca 2+ -induced movement of tropomyosin on native cardiac thin filaments revealed by cryoelectron microscopy. PNAS. 2017;261:201700868. doi: 10.1073/pnas.1700868114. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Risi C, Schäfer LU, Belknap B, Pepper I, White HD, Schröder GF, Galkin VE. High-Resolution Cryo-EM Structure of the Cardiac Actomyosin Complex. Structure. 2021;29:50–60. doi: 10.1016/j.str.2020.09.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Robert-Paganin J, Pylypenko O, Kikuti C, Sweeney HL, Houdusse A. Force Generation by Myosin Motors: A Structural Perspective. Chemical Reviews. 2020;120:5–35. doi: 10.1021/acs.chemrev.9b00264. [DOI] [PubMed] [Google Scholar]
- Robert-Paganin J, Xu X-P, Swift MF, Auguin D, Robblee JP, Lu H, Fagnant PM, Krementsova EB, Trybus KM, Houdusse A, Volkmann N, Hanein D. The actomyosin interface contains an evolutionary conserved core and an ancillary interface involved in specificity. Nature Communications. 2021;12:1811. doi: 10.1038/s41467-021-22093-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rosenfeld SS, Sweeney HL. A model of myosin V processivity. The Journal of Biological Chemistry. 2004;279:40100–40111. doi: 10.1074/jbc.M402583200. [DOI] [PubMed] [Google Scholar]
- Scheres SHW. RELION: implementation of a Bayesian approach to cryo-EM structure determination. Journal of Structural Biology. 2012;180:519–530. doi: 10.1016/j.jsb.2012.09.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schröder RR. The Structure of Acto-Myosin. Advances in Experimental Medicine and Biology. 2020;1239:41–59. doi: 10.1007/978-3-030-38062-5_4. [DOI] [PubMed] [Google Scholar]
- Sellers JR. Myosins: a diverse superfamily. Biochimica et Biophysica Acta. 2000;1496:3–22. doi: 10.1016/s0167-4889(00)00005-7. [DOI] [PubMed] [Google Scholar]
- Smith CA, Rayment I. X-ray structure of the magnesium(II).ADP.vanadate complex of the Dictyostelium discoideum myosin motor domain to 1.9 A resolution. Biochemistry. 1996;35:5404–5417. doi: 10.1021/bi952633+. [DOI] [PubMed] [Google Scholar]
- Stabrin M, Schoenfeld F, Wagner T, Pospich S, Gatsogiannis C, Raunser S. TranSPHIRE: automated and feedback-optimized on-the-fly processing for cryo-EM. Nature Communications. 2020;11:5714. doi: 10.1038/s41467-020-19513-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sun M, Oakes JL, Ananthanarayanan SK, Hawley KH, Tsien RY, Adams SR, Yengo CM. Dynamics of the upper 50-kDa domain of myosin V examined with fluorescence resonance energy transfer. The Journal of Biological Chemistry. 2006;281:5711–5717. doi: 10.1074/jbc.M508103200. [DOI] [PubMed] [Google Scholar]
- Sweeney HL, Houdusse A. Structural and functional insights into the Myosin motor mechanism. Annual Review of Biophysics. 2010;39:539–557. doi: 10.1146/annurev.biophys.050708.133751. [DOI] [PubMed] [Google Scholar]
- Sweeney HL, Houdusse A, Robert-Paganin J. Myosin Structures. Advances in Experimental Medicine and Biology. 2020;1239:7–19. doi: 10.1007/978-3-030-38062-5_2. [DOI] [PubMed] [Google Scholar]
- Szent-Györgyi AG. The early history of the biochemistry of muscle contraction. The Journal of General Physiology. 2004;123:631–641. doi: 10.1085/jgp.200409091. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Takagi Y, Homsher EE, Goldman YE, Shuman H. Force generation in single conventional actomyosin complexes under high dynamic load. Biophysical Journal. 2006;90:1295–1307. doi: 10.1529/biophysj.105.068429. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tang G, Peng L, Baldwin PR, Mann DS, Jiang W, Rees I, Ludtke SJ. EMAN2: an extensible image processing suite for electron microscopy. Journal of Structural Biology. 2007;157:38–46. doi: 10.1016/j.jsb.2006.05.009. [DOI] [PubMed] [Google Scholar]
- Thomas DD, Kast D, Korman VL. Site-directed spectroscopic probes of actomyosin structural dynamics. Annual Review of Biophysics. 2009;38:347–369. doi: 10.1146/annurev.biophys.35.040405.102118. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vahokoski J, Calder LJ, Lopez AJ, Molloy JE, Rosenthal PB, Kursula I. High-Resolution Structures of Malaria Parasite Actomyosin and Actin Filaments. bioRxiv. 2020 doi: 10.1101/2020.07.02.183871. [DOI] [PMC free article] [PubMed]
- Vale RD. Switches, latches, and amplifiers: common themes of G proteins and molecular motors. The Journal of Cell Biology. 1996;135:291–302. doi: 10.1083/jcb.135.2.291. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Veigel C, Schmitz S, Wang F, Sellers JR. Load-dependent kinetics of myosin-V can explain its high processivity. Nature Cell Biology. 2005;7:861–869. doi: 10.1038/ncb1287. [DOI] [PubMed] [Google Scholar]
- Volkmann N, Liu H, Hazelwood L, Krementsova EB, Lowey S, Trybus KM, Hanein D. The structural basis of myosin V processive movement as revealed by electron cryomicroscopy. Molecular Cell. 2005;19:595–605. doi: 10.1016/j.molcel.2005.07.015. [DOI] [PubMed] [Google Scholar]
- von der Ecken J, Heissler SM, Pathan-Chhatbar S, Manstein DJ, Raunser S. Cryo-EM structure of a human cytoplasmic actomyosin complex at near-atomic resolution. Nature. 2016;534:724–728. doi: 10.1038/nature18295. [DOI] [PubMed] [Google Scholar]
- Wagner T, Merino F, Stabrin M, Moriya T, Antoni C, Apelbaum A, Hagel P, Sitsel O, Raisch T, Prumbaum D, Quentin D, Roderer D, Tacke S, Siebolds B, Schubert E, Shaikh TR, Lill P, Gatsogiannis C, Raunser S. SPHIRE-crYOLO is a fast and accurate fully automated particle picker for cryo-EM. Communications Biology. 2019;2:218. doi: 10.1038/s42003-019-0437-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wagner T. Cinderella. 2020. [August 27, 2020]. https://sphire.mpg.de/wiki/doku.php?id=auto_2d_class_selection
- Wagner T, Lusnig L, Pospich S, Stabrin M, Schönfeld F, Raunser S. Two particle-picking procedures for filamentous proteins: SPHIRE-crYOLO filament mode and SPHIRE-STRIPER. Acta Crystallographica. Section D, Structural Biology. 2020;76:613–620. doi: 10.1107/S2059798320007342. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Walker JE, Saraste M, Runswick MJ, Gay NJ. Distantly related sequences in the alpha- and beta-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold. The EMBO Journal. 1982;1:945–951. doi: 10.1002/j.1460-2075.1982.tb01276.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Walker ML, Burgess SA, Sellers JR, Wang F, Hammer JA, Trinick J, Knight PJ. Two-headed binding of a processive myosin to F-actin. Nature. 2000;405:804–807. doi: 10.1038/35015592. [DOI] [PubMed] [Google Scholar]
- Walklate J, Ujfalusi Z, Geeves MA. Myosin isoforms and the mechanochemical cross-bridge cycle. The Journal of Experimental Biology. 2016;219:168–174. doi: 10.1242/jeb.124594. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Whittaker M, Wilson-Kubalek EM, Smith JE, Faust L, Milligan RA, Sweeney HL. A 35-A movement of smooth muscle myosin on ADP release. Nature. 1995;378:748–751. doi: 10.1038/378748a0. [DOI] [PubMed] [Google Scholar]
- Woolner S, Bement WM. Unconventional myosins acting unconventionally. Trends in Cell Biology. 2009;19:245–252. doi: 10.1016/j.tcb.2009.03.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wulf SF, Ropars V, Fujita-Becker S, Oster M, Hofhaus G, Trabuco LG, Pylypenko O, Sweeney HL, Houdusse AM, Schröder RR. Force-producing ADP state of myosin bound to actin. PNAS. 2016;113:E1844–E1852. doi: 10.1073/pnas.1516598113. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yang Z, Fang J, Chittuluru J, Asturias FJ, Penczek PA. Iterative stable alignment and clustering of 2D transmission electron microscope images. Structure. 2012;20:237–247. doi: 10.1016/j.str.2011.12.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yengo CM, De la Cruz EM, Safer D, Ostap EM, Sweeney HL. Kinetic characterization of the weak binding states of myosin V. Biochemistry. 2002;41:8508–8517. doi: 10.1021/bi015969u. [DOI] [PubMed] [Google Scholar]
- Zhang K. Gctf: Real-time CTF determination and correction. Journal of Structural Biology. 2016;193:1–12. doi: 10.1016/j.jsb.2015.11.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zheng SQ, Palovcak E, Armache JP, Verba KA, Cheng Y, Agard DA. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nature Methods. 2017;14:331–332. doi: 10.1038/nmeth.4193. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhong ED, Bepler T, Berger B, Davis JH. CryoDRGN: reconstruction of heterogeneous cryo-EM structures using neural networks. Nature Methods. 2021;18:176–185. doi: 10.1038/s41592-020-01049-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zimmermann D, Santos A, Kovar DR, Rock RS. Actin age orchestrates myosin-5 and myosin-6 run lengths. Current Biology. 2015;25:2057–2062. doi: 10.1016/j.cub.2015.06.033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zivanov J, Nakane T, Forsberg BO, Kimanius D, Hagen WJ, Lindahl E, Scheres SH. New tools for automated high-resolution cryo-EM structure determination in RELION-3. eLife. 2018;7:e42166. doi: 10.7554/eLife.42166. [DOI] [PMC free article] [PubMed] [Google Scholar]